<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples - Anglemyer, A - 2013 | Cochrane Library</title> <meta content="Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples - Anglemyer, A - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009153.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples - Anglemyer, A - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009153.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009153.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples" name="citation_title"/> <meta content="Andrew Anglemyer" name="citation_author"/> <meta content="University of California, San Francisco" name="citation_author_institution"/> <meta content="George W Rutherford" name="citation_author"/> <meta content="University of California, San Francisco" name="citation_author_institution"/> <meta content="GRutherford@psg.ucsf.edu" name="citation_author_email"/> <meta content="Tara Horvath" name="citation_author"/> <meta content="University of California, San Francisco" name="citation_author_institution"/> <meta content="Rachel C Baggaley" name="citation_author"/> <meta content="World Health Organization" name="citation_author_institution"/> <meta content="Matthias Egger" name="citation_author"/> <meta content="Institute of Social and Preventive Medicine" name="citation_author_institution"/> <meta content="Nandi Siegfried" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD009153.pub3" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/04/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009153.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009153.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009153.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Sexual Partners; Anti‐HIV Agents [*therapeutic use]; CD4 Lymphocyte Count; Cohort Studies; HIV Infections [*prevention &amp; control, *transmission]; HIV Seronegativity; HIV Seropositivity [drug therapy, transmission]; HIV Serosorting" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009153.pub3&amp;doi=10.1002/14651858.CD009153.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="77cjsSG8";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009153\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009153\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009153.pub3",title:"Antiretroviral therapy for prevention of HIV transmission in HIV\\u2010discordant couples",firstPublishedDate:"Apr 30, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane HIV/AIDS Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009153.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009153.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009153.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009153.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009153.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009153.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009153.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009153.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009153.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009153.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2875 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009153.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-sec-0070"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-sec-0064"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/appendices#CD009153-sec-0075"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/table_n/CD009153StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/table_n/CD009153StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information#CD009153-cr-0002">Andrew Anglemyer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information#CD009153-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>George W Rutherford</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information#CD009153-cr-0004">Tara Horvath</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information#CD009153-cr-0005">Rachel C Baggaley</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information#CD009153-cr-0006">Matthias Egger</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information#CD009153-cr-0007">Nandi Siegfried</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information/en#CD009153-sec-0083">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 April 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009153.pub3">https://doi.org/10.1002/14651858.CD009153.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009153-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009153-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009153-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009153-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009153-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009153-abs-0001" lang="en"> <section id="CD009153-sec-0001"> <h3 class="title" id="CD009153-sec-0001">Background</h3> <p>Antiretroviral drugs have been shown to reduce risk of mother‐to‐child transmission of human immunodeficiency virus (HIV) and are also widely used for post‐exposure prophylaxis for parenteral and sexual exposures. Sexual transmission may be lower in couples in which one partner is infected with HIV and the other is not and the infected partner is on antiretroviral therapy (ART). </p> </section> <section id="CD009153-sec-0002"> <h3 class="title" id="CD009153-sec-0002">Objectives</h3> <p>To determine if ART use in an HIV‐infected member of an HIV‐discordant couple is associated with lower risk of HIV transmission to the uninfected partner compared to untreated discordant couples. </p> </section> <section id="CD009153-sec-0003"> <h3 class="title" id="CD009153-sec-0003">Search methods</h3> <p>We used standard Cochrane methods to search electronic databases and conference proceedings with relevant search terms without limits to language. </p> </section> <section id="CD009153-sec-0004"> <h3 class="title" id="CD009153-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCT), cohort studies and case‐control studies of HIV‐discordant couples in which the HIV‐infected member of the couple was being treated or not treated with ART </p> </section> <section id="CD009153-sec-0005"> <h3 class="title" id="CD009153-sec-0005">Data collection and analysis</h3> <p>Abstracts of all trials identified by electronic or bibliographic scanning were examined independently by two authors. We initially identified 3,833 references and examined 87 in detail for study eligibility. Data were abstracted independently using a standardised abstraction form. </p> </section> <section id="CD009153-sec-0006"> <h3 class="title" id="CD009153-sec-0006">Main results</h3> <p>One RCT and nine observational studies were included in the review. These ten studies identified 2,112 episodes of HIV transmission, 1,016 among treated couples and 1,096 among untreated couples. The rate ratio for the single randomised controlled trial was 0.04 [95% CI 0.00, 0.27]. All index partners in this study had CD4 cell counts at baseline of 350‐550 cells/µL. Similarly, the summary rate ratio for the nine observational studies was 0.58 [95% CI 0.35, 0.96], with substantial heterogeneity (I<sup>2</sup>=64%). After excluding two studies with inadequate person‐time data, we estimated a summary rate ratio of 0.36 [95% CI 0.17, 0.75] with substantial heterogeneity (I<sup>2</sup>=62%). We also performed subgroup analyses among the observational studies to see if the effect of ART on prevention of HIV differed by the index partner's CD4 cell count. Among couples in which the infected partner had ≥350 CD4 cells/µL, we estimated a rate ratio of 0.12 [95% CI 0.01, 1.99]. In this subgroup, there were 247 transmissions in untreated couples and 30 in treated couples. </p> </section> <section id="CD009153-sec-0007"> <h3 class="title" id="CD009153-sec-0007">Authors' conclusions</h3> <p>ART is a potent intervention for prevention of HIV in discordant couples in which the index partner has ≤550 CD4 cells/µL. A recent multicentre RCT confirms the suspected benefit seen in earlier observational studies and reported in more recent ones. Questions remain about durability of protection, the balance of benefits and adverse events associated with earlier therapy, long‐term adherence and transmission of ART‐resistant strains to partners. Resource limitations and implementation challenges must also be addressed. </p> <p>Counselling, support, and follow up, as well as mutual disclosure, may have a role in supporting adherence, so programmes should be designed with these components. In addition to ART provision, the operational aspects of delivering such programmes must be considered. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009153-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009153-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009153-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009153-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009153-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009153-abs-0005">Bahasa Malaysia</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009153-abs-0004" lang="en"> <h3>Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples</h3> <p>Antiretroviral drugs can prevent transmission of HIV from an infected sexual partner to an uninfected one, by suppressing viral replication. We found one randomised controlled trial and nine observational studies that examined this question. Overall we found that in couples in which the infected partner was being treated with antiretroviral drugs the uninfected partners had, at worst, more than 40% lower risk of being infected than in couples where the infected partner was not receiving treatment. Since the World Health Organization (WHO) already recommends antiretroviral treatment for all persons with ≤350 CD4 cells/µL, we also examined studies that had studied couples in which the infected partners had CD4 counts higher than this level. We found that there is strong evidence from the randomised controlled trial that in this group HIV was less likely to be transmitted to uninfected partners from treated infected partners than from untreated infected partners. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009153-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009153-sec-0070"></div> <h3 class="title" id="CD009153-sec-0071">Implications for practice</h3> <section id="CD009153-sec-0071"> <p>From the evidence provided by one RCT and nine observational studies, ART has been shown be a potent intervention for prevention of HIV in discordant couples. In 2012 WHO issued guidelines on serodiscordant couples to recommend that the partner living with HIV be offered ART regardless of CD4 count (<a href="./references#CD009153-bbs2-0059" title="World Health Organization. Guidance on couples HIV testing and counselling, including antiretroviral therapy for treatmentand prevention in serodiscordant couples: recommendations for a public health approach. Available from http://www.who.int/hiv/pub/guidelines/9789241501972/en/index.html [accessed 28 February 2013]. ">WHO 2012</a>). Patients in discordant couples beginning ART should be counselled that adherence to ART can also reduce their risk of transmitting HIV to their partners. A policy question remaining to be addressed is how much effort should be focused on treating individuals with ≥350 CD4 cells/µL when access to ART for persons with &lt;350 CD4 cells/µL is far from universal. Significant questions remain about durability of protection, cumulative antiretroviral toxicity, when to start treating an infected partner (for instance, at diagnosis or at a specific CD4 or plasma viral load level) and transmission of ART‐resistant strains to partners. </p> <p>The success of this intervention likely relies on good adherence, especially in stable couples. Programmes should be designed that include counselling, support, follow up and mutual disclosure, as these components may have a role in supporting adherence. In addition to ART provision, limitations in resources needed to implement such expanded ART indications must be addressed. </p> </section> <h3 class="title" id="CD009153-sec-0072">Implications for research</h3> <section id="CD009153-sec-0072"> <p>Additional data are needed on durability of protection for uninfected partners, adverse events associated with earlier initiation of ART, including effects of longer‐term ART, the potential for earlier development of antiretroviral resistance (resulting in a need to change regimens prematurely) and HIV morbidity, quality of life and the potential for risk compensation. Not only are there are multiple opportunities to examine these issues in existing cohorts, but there are several RCTs underway that will likely help strengthen the observational evidence. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009153-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009153-sec-0022"></div> <div class="table" id="CD009153-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part A)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part A)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Serodiscordant couples <br/> <b>Settings:</b> Botswana, Brazil, China, India, Italy Malawi, Kenya, Rwanda, South Africa, Spain, Thailand, Uganda, United States of America, Zambia and Zimbabwe <br/> <b>Intervention:</b> Antiretroviral Therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antiretroviral therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Virologically linked HIV incidence (RCT)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>17 per 1000</b><sup>5,8</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>1 per 1000</b> </p> <p>(0 to 5)<sup>5,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rate Ratio 0.04</b> <br/> (0.00 to 0.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1750</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕ <br/> <b>high</b><sup>5,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence (observational studies)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b> <br/> (19 to 51)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate Ratio 0.58</b> <br/> (0.35 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46204 <br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence (observational studies‐‐sensitivity analysis)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b> <br/> (8 to 36)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate Ratio 0.36</b> <br/> (0.17 to 0.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46560 <br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: CD4 subgroups (&lt;200 cells/µL) (observational studies)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b><sup>2,6</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 1000</b> <br/> (1 to 39)<sup>2,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.12</b> <br/> (0.02 to 0.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26594 <br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>5,7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: CD4 subgroups (200‐350 CD4 cells/µL) (observational studies)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 1000</b><sup>2,6</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (13 to 26)<sup>2,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.66</b> <br/> (0.47 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9595 <br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>3,8,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: CD4 subgroups (350 or more CD4 cells/µL) (observational studies)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 1000</b><sup>2,6</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> <br/> (0 to 49)<sup>2,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.12</b> <br/> (0.01 to 1.99.) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13426 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>5,8,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Virologically linked HIV incidence: CD4 subgroups (350 or more CD4 cells/µL) (RCT)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>17 per 1000<sup>5,8</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>1 per 1000</p> <p>(0 to 5)<sup>5,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.04</b> <br/> (0.00 to 0.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1750</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕ <br/> <b>high</b><sup>5,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>RCT:</b> randomised controlled trial; <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Less than 5% of sample was imputed due to missing information in the denominator. <br/> <sup>2</sup> Numerators and Denominators taken from text where possible. Numbers were not used to calculate the relative effect estimates. <br/> <sup>3</sup> Rate Ratio ˜ 0.50 <br/> <sup>4</sup> Two studies were removed due to differences in intervention or incomplete data. <br/> <sup>5</sup> RR &lt; 0.35 <br/> <sup>6</sup> Due to missing information in the denominator and/or numerator, some data were imputed from text. <br/> <sup>7</sup> No person time available for 3 out of 5 studies. <br/> <sup>8</sup> Few events and/or wide confidence interval. <br/> <sup>9</sup> No person time available for 2 out of 4 studies. <br/> <sup>10</sup> No person time available for 1 out of 3 studies. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009153-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part B)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part B)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Serodiscordant couples <br/> <b>Settings:</b> Botswana, Brazil, China, Italy, Kenya, Rwanda, South Africa, Spain, Tanzania, Uganda, and Zambia <br/> <b>Intervention:</b> Antiretroviral Therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antiretroviral therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: gender subgroup (female cases)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (10 to 88)<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.39</b> <br/> (0.13 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15608 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational studies only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: gender subgroup (male Cases)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b> <br/> (0 to 78)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.11</b> <br/> (0.01 to 1.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25073 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational studies only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: low‐/middle‐income countries</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (16 to 53)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.53</b> <br/> (0.29 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45029 <br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>3,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational studies only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: high income countries</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b> <br/> (10 to 57)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b> <br/> (0.33 to 1.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1061 <br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational studies only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Numerators and denominators taken from text where possible. Numbers were not used to calculate the relative effect estimates. <br/> <sup>2</sup> Due to missing information in the denominator and/or numerator, some data were imputed from text. <br/> <sup>3</sup> Few events and/or wide confidence interval. <br/> <sup>4</sup> RR ˜ 0.35 <br/> <sup>5</sup> Rate Ratio ˜ 0.50 </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009153-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009153-sec-0023"></div> <p>Antiretroviral drugs have been shown to reduce risk of mother‐to‐child transmission of human immunodeficiency virus (HIV) (<a href="./references#CD009153-bbs2-0055" title="SiegfriedN , van derMerweL , BrocklehurstP , SintTT . Antiretrovirals for reducing the risk of mother‐to‐child transmission of HIV infection. Cochrane Database of Systematic Reviews2011, Issue 7. [PUBMED: 21735394] ">Siegfried 2011</a>), and are widely used for post‐exposure prophylaxis for parenteral and sexual exposures (<a href="./references#CD009153-bbs2-0061" title="YoungTN , ArensFJ , KennedyGE , LaurieJW , RutherfordG . Antiretroviral post‐exposure prophylaxis (PEP) for occupational HIV exposure.. Cochrane Database of Systematic Reviews 2007 Jan 24, Issue 1. [PUBMED: CD002835] ">Young 2007</a>, <a href="./references#CD009153-bbs2-0039" title="GrantRM . Antiretroviral agents used by HIV‐uninfected persons for prevention: pre‐ and postexposure prophylaxis. Clin Infect Dis2010;50(Suppl 3):S96‐101. ">Grant 2010</a>), although these indications have not been examined in randomised controlled trials (RCT) (<a href="./references#CD009153-bbs2-0061" title="YoungTN , ArensFJ , KennedyGE , LaurieJW , RutherfordG . Antiretroviral post‐exposure prophylaxis (PEP) for occupational HIV exposure.. Cochrane Database of Systematic Reviews 2007 Jan 24, Issue 1. [PUBMED: CD002835] ">Young 2007</a>). They are also efficacious in preventing acquisition of HIV infection by uninfected individuals (pre‐exposure prophylaxis) (<a href="./references#CD009153-bbs2-0051" title="OkwunduCI , UthmanOA , OkoromahCA . Antiretroviral pre‐exposure prophylaxis (PrEP) for preventing HIV in high‐risk individuals. Cochrane Database of Systematic Reviews2012, Issue 7. [PUBMED: 22786505] ">Okwundu 2012</a>). Sexual transmission is lower in couples in which one partner is infected with HIV and the other is not and the infected partner is on antiretroviral therapy (ART) (<a href="./references#CD009153-bbs2-0063" title="AnglemyerA , Rutherford GeorgeW , Baggaley RachelC , EggerM , SiegfriedN . Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2011, issue 8. [CENTRAL: CD009153] ">Anglemyer 2011b</a>), and models indicate widespread prevention benefit if large numbers of infected patients in a population are treated (<a href="./references#CD009153-bbs2-0038" title="GranichRM , GilksCF , DyeC , DeCockKM , WilliamsBG . Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet2009;373:48‐58. ">Granich 2009</a>). Ecological studies from Taiwan (<a href="./references#CD009153-bbs2-0035" title="FangCT , HsuHM , TwuSJ , ChenMY , ChangYY , HwangJS , WangJD , ChuangCY . Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis2004;195(5):879‐85. ">Fang 2004</a>), British Columbia (<a href="./references#CD009153-bbs2-0060" title="WoodE , KerrT , MarshallB , et al. Longitudinal community plasma HIV‐1 RNA concentrations and incidence of HIV‐1 among injecting drug users: prospective cohort study. BMJ2009;338:b1659. ">Wood 2009</a>, <a href="./references#CD009153-bbs2-0036" title="GillVS , LimaVD , ZhangW . Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. Clin Infect Dis2010;50:98‐105. ">Gill 2010</a>, <a href="./references#CD009153-bbs2-0049" title="MontanerJS , LimaVD , BarriosR , et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population‐based study. Lancet 2010 Aug 14;376(9740):532‐9. ">Montaner 2010</a>) and San Francisco (<a href="./references#CD009153-bbs2-0052" title="PorcoT , Page‐ShaferK , ChengA , CharleboisE , GrantRM , OsmondDH . Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.. AIDS2004;18:81‐88. ">Porco 2004</a>, <a href="./references#CD009153-bbs2-0031" title="DasM , ChuPL , SantosGM , ScheerS , VittinghoffE , McFarlandW , ColfaxGN . Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One2010;5:e11068. ">Das 2010</a>) have found that transmission has decreased as the proportion of treated patients increases and community viral load decreases (<a href="./references#CD009153-bbs2-0031" title="DasM , ChuPL , SantosGM , ScheerS , VittinghoffE , McFarlandW , ColfaxGN . Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One2010;5:e11068. ">Das 2010</a>). </p> <p>In a cohort analysis of couples followed in a trial of sexually transmitted disease control for prevention of HIV in the era before ART was widely available in rural Africa, risk of sexual transmission in discordant couples was lowest in couples in which the infected partner had an HIV serum viral load of &lt;400 copies/mL (<a href="./references#CD009153-bbs2-0023" title="QuinnTC , WawerMJ , SewankamboN , et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1.. N Engl J Med2000;342:921‐29. ">Quinn 2000</a>). Similarly, data from trials and cohort studies of mother‐to‐child transmission of HIV have demonstrated that mothers with the lowest viral loads are the least likely to transmit (<a href="./references#CD009153-bbs2-0045" title="JourdainG , MaryJY , CoeurSL , Ngo‐Giang‐HuongN , YuthavisuthiP , LimtrakulA , TraisathitP , McIntoshK , LallemantM , Perinatal HIV Prevention Trial Group, Thailand . Risk factors for in utero or intrapartum mother‐to‐child transmission of human immunodeficiency virus type 1 in Thailand. J Infect Dis2007;196:1629‐36. ">Jourdain 2007</a>). While plasma (or serum in the case of <a href="./references#CD009153-bbs2-0023" title="QuinnTC , WawerMJ , SewankamboN , et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1.. N Engl J Med2000;342:921‐29. ">Quinn 2000</a>) viral loads do not necessarily directly correlate with viral loads in semen or cervico‐vaginal secretions and HIV can continue to be shed despite non‐detectable plasma viral loads (<a href="./references#CD009153-bbs2-0054" title="ShethPM , KovacsC , KemalKS , JonesRB , RaboudJM , PilonR , laPorteC , OstrowskiM , LouftyM , BurgerH , WeiserB , KaulR , Toronto Mucosal Immunology Group. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.. AIDS2009;23:2050‐54. ">Sheth 2009</a>), the absence of detectable HIV RNA in plasma roughly corresponds to lower levels of HIV RNA in genital tract secretions (<a href="./references#CD009153-bbs2-0057" title="VettoreMV , SchecterM , MeloMF , CoechatLJ , BarrosoPF . Genital HIV‐1 viral load is correlated with blood plasma HIV‐1 viral load in Brazilian women and is reduced by antiretroviral therapy.. J Infect2006;52:290‐93. ">Vettore 2006</a>, <a href="./references#CD009153-bbs2-0046" title="LorellaG , laPorteC , PilonR , ZhangG , KarnauchowT , MacPhersonP . Discordance in HIV‐1 viral loads and antiretroviral drug concentrations among semen and blood plasma. HIV Med2009;10:548‐54. ">Lorella 2009</a>). Moreover, a recently published simulation model aimed to estimate the risk of HIV transmission, in the context of condom use, from homosexual men treated with ART to their partners (<a href="./references#CD009153-bbs2-0042" title="HallettT , SmitC , GarnettG , deWolfF . Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV‐uninfected partners. Sex Transm Infect2011;87:17‐21. ">Hallett 2011</a>) and found that, even when never using condoms with long‐term partners, the predicted risk of transmission to long‐term partners was only 22%. </p> <p>Taken together this body of literature suggests that treating an infected individual with ART may decrease the risk of sexual transmission to his or her uninfected partners. In this review we examine whether treating an HIV‐infected partner (or "index" partner) with ART is associated with decreased risk of acquiring HIV in an uninfected member of a discordant couple. </p> <section id="CD009153-sec-0024"> <h3 class="title" id="CD009153-sec-0024">Description of the condition</h3> <p>HIV infection is a chronic retroviral infection of humans that is almost universally fatal if left untreated. HIV can be transmitted sexually, parenterally or perinatally; globally sexual transmission accounted for about 70% of the 2.7 million new HIV infections in 2008 (<a href="./references#CD009153-bbs2-0056" title="Joint United Nations Programme on HIV/AIDS, World Health Organization. AIDS epidemic update: November 2009. WHO, Geneva, Switzerland. ">UNAIDS 2009</a>). Data from Africa suggest that more than half of new infections are occurring in stable couples who are serodiscordant for HIV infection, meaning that one member of the couple is infected and the other is not (<a href="./references#CD009153-bbs2-0033" title="DunkleKL , StephensonR , KaritaE , et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet2008;371:2183‐91. ">Dunkle 2008</a>, <a href="./references#CD009153-bbs2-0047" title="MerminJ , MusinguziJ , OpioA , et al. Risk factors for recent HIV infection in Uganda. JAMA2008;300:540‐49. ">Mermin 2008</a>). </p> </section> <section id="CD009153-sec-0025"> <h3 class="title" id="CD009153-sec-0025">Description of the intervention</h3> <p>Use of any antiretroviral drugs alone or in combination in HIV‐infected members of discordant couples. </p> <p><b>Inclusion criteria:</b> </p> <p> <ul id="CD009153-list-0001"> <li> <p>Randomised controlled trial (RCT), cohort study or case‐control study</p> </li> <li> <p>Compares HIV‐discordant couples in which the HIV‐infected member is treated or not treated </p> </li> <li> <p>Provides sufficient regimen‐specific information about drugs to compare regimens and outcomes of interest </p> </li> </ul> </p> <p><b>Exclusion criteria:</b> </p> <p> <ul id="CD009153-list-0002"> <li> <p>Studies in which all HIV‐infected members of discordant couples are either all treated or all not treated </p> </li> <li> <p>Letter, editorial, non‐systematic review, case report, case series, cross‐sectional study </p> </li> </ul> </p> </section> <section id="CD009153-sec-0026"> <h3 class="title" id="CD009153-sec-0026">How the intervention might work</h3> <p>By suppressing HIV replication systemically and decreasing HIV shedding in the genital tract. </p> </section> <section id="CD009153-sec-0027"> <h3 class="title" id="CD009153-sec-0027">Why it is important to do this review</h3> <p>If there is, indeed, prevention benefit from ART, in addition to its well‐established therapeutic efficacy, the weight of evidence may shift to treating infected patients earlier in the course of their infection than is currently recommended (<a href="./references#CD009153-bbs2-0058" title="World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach.. WHO, Geneva, Switzerland2010. ">WHO 2010</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009153-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009153-sec-0028"></div> <p>To assess if ART is associated with decreased risk of HIV transmission from an infected sexual partner to an uninfected sexual partner. Additionally, this review aims to assess specifically if ART in a patient with ≥350 CD4 cells/µL is also associated with a lowered risk of HIV transmission. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009153-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009153-sec-0029"></div> <section id="CD009153-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009153-sec-0031"> <h4 class="title">Types of studies</h4> <p>RCTs, cohort studies and case‐control studies that included data and analysis for the comparison of interest. </p> </section> <section id="CD009153-sec-0032"> <h4 class="title">Types of participants</h4> <p>HIV‐discordant couples that is, stable sexual partnerships in which one member is infected with HIV and the other uninfected. Studies with heterosexual or homosexual couples were eligible for inclusion. </p> </section> <section id="CD009153-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Use of any antiretroviral drugs alone or in combination in HIV‐infected members of discordant couples. Variations of interest included patients receiving HIV monotherapy, those receiving dual therapy and those receiving the current standard of three or more antiretroviral drugs (<a href="./references#CD009153-bbs2-0045" title="JourdainG , MaryJY , CoeurSL , Ngo‐Giang‐HuongN , YuthavisuthiP , LimtrakulA , TraisathitP , McIntoshK , LallemantM , Perinatal HIV Prevention Trial Group, Thailand . Risk factors for in utero or intrapartum mother‐to‐child transmission of human immunodeficiency virus type 1 in Thailand. J Infect Dis2007;196:1629‐36. ">Jourdain 2007</a>). </p> </section> <section id="CD009153-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD009153-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009153-list-0003"> <li> <p>Incident HIV Infection</p> </li> <li> <p>Incident HIV Infection with viral isolates matched from index patient to newly infected partner </p> </li> </ul> </p> </section> <section id="CD009153-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009153-list-0004"> <li> <p>Acquisition of primary drug‐resistant HIV. This is defined as an incident infection with an HIV strain resistant to one or more standard antiretroviral drugs. </p> </li> <li> <p>Severe adverse events in participants receiving treatment (Grade IV and life‐threatening)</p> </li> </ul> </p> </section> </section> </section> <section id="CD009153-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <p>See search methods used in reviews by the Cochrane Collaborative Review Group on HIV Infection and AIDS. </p> <section id="CD009153-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We formulated a comprehensive and exhaustive search strategy in an attempt to identify all relevant studies regardless of language or publication status (published, unpublished, in press and in progress). Full details of the Cochrane HIV/AIDS Review Group methods and the journals hand‐searched are published in the section on Collaborative Review Groups in The Cochrane Library. </p> <p><b>Journal and trials databases</b> <br/> <br/> We searched the following electronic databases, in the period from 01 January 1987 to 31 August 2012: </p> <p> <ul id="CD009153-list-0005"> <li> <p>PubMed</p> </li> <li> <p>EMBASE</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Web of Science</p> </li> <li> <p>LILACS</p> </li> </ul> </p> <p>Along with MeSH terms and relevant keywords, we used the Cochrane Highly Sensitive Search Strategy for identifying reports of RCTs in MEDLINE (<a href="./references#CD009153-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons Ltd, 2008. ">Higgins 2008</a>), and the Cochrane HIV/AIDS Group's existing strategies for identifying references relevant to HIV/AIDS. The search strategy was iterative, in that references of included studies were searched for additional references. All languages were included. See <a href="./appendices#CD009153-sec-0076">Appendix 1</a> for example of our PubMed search strategy, which was modified as appropriate for use in the other databases. In searching conference abstract archives, it was not possible to perform complex searches. Instead, we used a variety of relevant terms, individually and in simple combinations. See <a href="./appendices#CD009153-sec-0077">Appendix 2</a> for these terms, and the yields from these searches. </p> <p>Using a variety of relevant terms, we also searched the clinical trials registry at the US National Institutes of Health's ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>). </p> <p><b>Limits.</b> The searches were performed without limits to language or setting and limited to human studies published from 1987 (start of the antiretroviral era) to the present. </p> </section> <section id="CD009153-sec-0039"> <h4 class="title">Searching other resources</h4> <p><b>Conference abstract databases</b> </p> <p>Using a variety of relevant terms, we searched the Aegis archive of HIV/AIDS conference abstracts (<a href="http://www.aegis.org" target="_blank">www.aegis.org</a>), which includes the following conferences: </p> <p> <ul id="CD009153-list-0006"> <li> <p>British HIV/AIDS Association, 2001‐2008</p> </li> <li> <p>Conference on Retroviruses and Opportunistic Infections (CROI), 1994‐2008</p> </li> <li> <p>European AIDS Society Conference, 2001 and 2003</p> </li> <li> <p>International AIDS Society, Conference on HIV Pathogenesis, Treatment and Prevention (IAS), 2001‐2005 </p> </li> <li> <p>International AIDS Society, International AIDS Conference (IAC), 1985‐2004</p> </li> <li> <p>US National HIV Prevention Conference, 1999, 2003, and 2005</p> </li> </ul> </p> <p>We also searched the CROI and International AIDS Society web sites for abstracts presented at conferences subsequent to those listed above (CROI, 2009‐2012; IAC, 2006‐2012; IAS, 2007‐2011). <br/> <br/> <b>Researchers and relevant organizations.</b> We contacted individual researchers working in the field, such as the AIDS Clinical Trials Group, and policymakers based in inter‐governmental organizations including the Joint United Nations Programme on HIV/AIDS (UNAIDS) and WHO to identify studies either completed or ongoing. </p> <p><b>Reference lists.</b> We checked the reference lists of all studies identified by the above methods and examined the bibliographies of any systematic reviews, meta‐analyses, or current guidelines we identified during the search process. </p> </section> </section> <section id="CD009153-sec-0040"> <h3 class="title" id="CD009153-sec-0040">Data collection and analysis</h3> <p>The methodology for data collection and analysis was based on the guidance of Cochrane Handbook of Systematic Reviews of Interventions (<a href="./references#CD009153-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons Ltd, 2008. ">Higgins 2008</a>). Abstracts of all trials identified by electronic or bibliographic scanning were examined by two authors (AA and GWR) working independently. Where necessary, the full text was obtained to determine the eligibility of studies for inclusion. </p> <section id="CD009153-sec-0041"> <h4 class="title">Selection of studies</h4> <p>After removing duplicate references, One author (TH) made the first broad cut of these results, excluding those that were clearly irrelevant (e.g. animal studies, editorials, paediatric studies, studies without HIV endpoints). </p> <p>Two authors (AA and GWR) then independently selected potentially relevant studies by scanning the titles, abstracts, and descriptor terms of the remaining references and applied the inclusion criteria. Irrelevant reports were discarded, and the full article or abstract was obtained for all potentially relevant or uncertain reports. The two authors independently applied the inclusion criteria. Studies were reviewed for relevance, based on study design, types of participants, exposures and outcomes measures. A neutral third party was available to adjudicate any disagreements that could not have been resolved by discussion. </p> </section> <section id="CD009153-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>After initial search and article screening, two reviewers independently double‐coded and entered information from each selected study onto standardised data extraction forms. Extracted information included:<b> </b> </p> <p> <ul id="CD009153-list-0007"> <li> <p><b>Study details</b><i>:</i> citation, start and end dates, location, study design and details. </p> </li> </ul> <ul id="CD009153-list-0008"> <li> <p><b>Participant details</b><i>:</i> study population eligibility (inclusion and exclusion) criteria, ages, population size, attrition rate, details of HIV diagnosis and disease and any clinical, immunologic or virologic staging or laboratory information on the infected partner. </p> </li> </ul> <ul id="CD009153-list-0009"> <li> <p><b>Interventions details:</b> Drug names, doses, duration and any other information on adherence or resistance. </p> </li> </ul> <ul id="CD009153-list-0010"> <li> <p><b>Outcome details:</b> Incident HIV infection in the uninfected partner, acquisition of a drug‐resistant strain of HIV </p> </li> </ul> </p> </section> <section id="CD009153-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Cochrane Collaboration tool for assessing the risk of bias for each individual study and present results in a summary table (<a href="#CD009153-fig-0001">Figure 1</a>). For trials, the Cochrane tool assesses risk of bias in individual studies across six domains: sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other potential biases. </p> <div class="figure" id="CD009153-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009153-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <p><b>Sequence generation</b> </p> <p> <ul id="CD009153-list-0011"> <li> <p>Adequate: investigators described a random component in the sequence generation process, such as the use of random number table, coin tossing, card or envelope shuffling, etc. </p> </li> <li> <p>Inadequate: investigators described a non‐random component in the sequence generation process, such as the use of odd or even date of birth, algorithm based on the day or date of birth, hospital, or clinic record number. </p> </li> <li> <p>Unclear: insufficient information to permit judgement of the sequence generation process.</p> </li> </ul> </p> <p><b>Allocation concealment</b> </p> <p> <ul id="CD009153-list-0012"> <li> <p>Adequate: participants and the investigators enrolling participants cannot foresee assignment (e.g., central allocation; or sequentially numbered, opaque, sealed envelopes). </p> </li> <li> <p>Inadequate: participants and investigators enrolling participants can foresee upcoming assignment (e.g., an open random allocation schedule, a list of random numbers); or envelopes were unsealed or non‐opaque or not sequentially numbered. </p> </li> <li> <p>Unclear: insufficient information to permit judgement of the allocation concealment or the method not described. </p> </li> </ul> </p> <p><b>Blinding</b> </p> <p> <ul id="CD009153-list-0013"> <li> <p>Adequate: blinding of the participants, key study personnel, and outcome assessor, and unlikely that the blinding could have been broken. No blinding in the situation where non‐blinding is not likely to introduce bias. </p> </li> <li> <p>Inadequate: no blinding or incomplete blinding when the outcome is likely to be influenced by lack of blinding. </p> </li> <li> <p>Unclear: insufficient information to permit judgement of adequacy or otherwise of the blinding. </p> </li> </ul> </p> <p><b>Incomplete outcome data</b> </p> <p> <ul id="CD009153-list-0014"> <li> <p>Adequate: no missing outcome data, reasons for missing outcome data unlikely to be related to true outcome, or missing outcome data balanced in number across groups. </p> </li> <li> <p>Inadequate: reason for missing outcome data likely to be related to true outcome, with either imbalance in number across groups or reasons for missing data. </p> </li> <li> <p>Unclear: insufficient reporting of attrition or exclusions.</p> </li> </ul> </p> <p><b>Selective reporting</b> </p> <p> <ul id="CD009153-list-0015"> <li> <p>Adequate: a protocol is available which clearly states the primary outcome as the same as in the final trial report. </p> </li> <li> <p>Inadequate: the primary outcome differs between the protocol and final trial report.</p> </li> <li> <p>Unclear: no trial protocol is available or there is insufficient reporting to determine if selective reporting is present. </p> </li> </ul> </p> <p><b>Other forms of bias</b> </p> <p> <ul id="CD009153-list-0016"> <li> <p>Adequate: there is no evidence of bias from other sources.</p> </li> <li> <p>Inadequate: there is potential bias present from other sources (e.g., early stopping of trial, fraudulent activity, extreme baseline imbalance, or bias related to specific study design). </p> </li> <li> <p>Unclear: insufficient information to permit judgement of adequacy or otherwise of other forms of bias. </p> </li> </ul> </p> <p>We used the <a href="./references#CD009153-bbs2-0050" title="WellsGA , SheaB , O'ConnellD , PetersonJ , WelchV , LososM , TugwellP . The Newcastle‐Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta‐analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. ">Newcastle‐Ottawa</a> Scale (<a href="./references#CD009153-bbs2-0050" title="WellsGA , SheaB , O'ConnellD , PetersonJ , WelchV , LososM , TugwellP . The Newcastle‐Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta‐analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. ">Newcastle‐Ottawa</a>) to assess the quality and risk of bias in non‐randomised studies. Specifically, the scale uses a star system to judge three general areas: selection of study groups, comparability of groups, and ascertainment of outcomes (in the case of cohort studies). As a result, this instrument can assess the quality of non‐randomised studies so that they can be used in a meta‐analysis or systematic review. Please see <a href="#CD009153-fig-0002">Figure 2</a> and <a href="./appendices#CD009153-sec-0078">Appendix 3</a> for details. </p> <div class="figure" id="CD009153-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Newcastle‐Ottawa Scale for Bias Assessment" data-id="CD009153-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Newcastle‐Ottawa Scale for Bias Assessment</p> </div> </div> </div> <p><b>Assessment of Quality of Evidence Across Studies</b> </p> <p>We assessed the quality of evidence across a body of evidence (i.e., multiple studies with similar interventions and outcomes) with the GRADE approach (<a href="./references#CD009153-bbs2-0041" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , SchunemannHJ , GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>), defining the quality of evidence for each outcome as “the extent to which one can be confident that an estimate of effect or association is close to the quantity of specific interest” (<a href="./references#CD009153-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons Ltd, 2008. ">Higgins 2008</a>). The quality rating across studies has four levels: high, moderate, low or very low. RCTs are categorised as high quality but can be downgraded; similarly, other types of controlled trials and observational studies are categorised as low quality but can be upgraded. Factors that decrease the quality of evidence include limitations in design, indirectness of evidence, unexplained heterogeneity or inconsistency of results, imprecision of results or high probability of publication bias. Factors that can increase the quality level of a body of evidence include a large magnitude of effect, if all plausible confounding would lead to an underestimation of effect and if there is a dose‐response gradient. </p> <p>See <a href="./full#CD009153-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD009153-tbl-0002">summary of findings Table 2</a>. </p> </section> <section id="CD009153-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>We used Review Manager 5 provided by the Cochrane Collaboration for statistical analysis and GRADEpro software (<a href="./references#CD009153-bbs2-0037" title="SchünemannH , BrozekJ , OxmanA . GRADEpro. GRADE Working Group, 2008. ">GRADEpro 2008</a>) to produce GRADE Summary of Findings tables and GRADE evidence profiles. We summarised dichotomous outcomes for effect in terms of risk ratio (RR), rate ratio and number needed to treat (NNT) with their 95% confidence intervals. Tests for interaction (i.e. Ratio of Risk Ratios, RRR) were performed to compare estimates within subgroups using methods described in Altman et al (<a href="./references#CD009153-bbs2-0027" title="AltmanD , BlandM . Interaction revisited: the difference between two estimates. BMJ2003;326:219. ">Altman 2003</a>). </p> <p>We summarised rate data in terms of rate ratios with their 95% confidence intervals. Standard errors for each estimate were estimated using methods described in Rothman et al (<a href="./references#CD009153-bbs2-0053" title="RothmanK , GreenlandS . Modern Epidemiology. Second Edition. Philadelphia, PA: Lippincott Williams and Wilkins, 1998. ">Rothman 1998</a>). </p> <p>We calculated summary statistics using meta‐analytic methods and present findings in GRADE Summary of Findings tables for all outcomes of interest.  </p> </section> <section id="CD009153-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual partner in the discordant couple who was uninfected at baseline in each study. </p> </section> <section id="CD009153-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>Study authors were contacted when missing data were an issue.</p> </section> <section id="CD009153-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity among the observational studies using the χ<sup>2</sup> statistic with a significance level of 0.10, and the I<sup>2</sup> statistic. We interpreted an I<sup>2</sup> estimate greater than 50% as indicating moderate or high levels of heterogeneity and investigated its causes by sensitivity analysis. If heterogeneity persisted, we reported potential reasons for the observed heterogeneity. </p> </section> <section id="CD009153-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed the potential for publication bias for the trial and for the observational studies using funnel plots. We attempted to minimise the potential for publication bias by our comprehensive search strategy that included evaluating published and unpublished literature. </p> </section> <section id="CD009153-sec-0049"> <h4 class="title">Data synthesis</h4> <p>When interventions and study populations were sufficiently similar across the different observational studies, we pooled the data across studies and estimated summary effect sizes using both fixed‐ and random‐effects models.  Specifically, we estimated the log(rate ratio) for each included study and used the inverse variance method to calculate study weights. The inverse variance method assumes that the variance for each study is inversely proportional to its importance, therefore more weight is given to studies with less variance than studies with greater variance. </p> <p>We summarised the quality of evidence for the trial and the observational studies separately for each outcome for which data were available in GRADE Summary of Findings tables and GRADE evidence profiles (<a href="./references#CD009153-bbs2-0041" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , SchunemannHJ , GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>). </p> </section> <section id="CD009153-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed sub‐group analysis in the observational studies by baseline CD4 counts in index partners and by gender of index partners. Heterogeneity was explored using further sub‐group analyses by setting (middle‐ or low‐ versus high‐income country). A test for interaction was performed for each subgroup comparison. </p> </section> <section id="CD009153-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>As pooled results were heterogeneous for the observational studies, we conducted sensitivity analyses to identify studies with outlying results for further examination. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009153-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009153-sec-0052"></div> <section id="CD009153-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD009153-sec-0054"> <h4 class="title">Results of the search</h4> <p>Searches for the first version of this review (<a href="./references#CD009153-bbs2-0062" title="AnglemyerA , RutherfordGW , EggerM , SiegfriedN . Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples. Cochrane Database of Systematic Reviews 2011 May 11, Issue 5. [CENTRAL: CD009153] ">Anglemyer 2011a</a>) were conducted on February 1, 2011. The review was updated three months later (<a href="./references#CD009153-bbs2-0063" title="AnglemyerA , Rutherford GeorgeW , Baggaley RachelC , EggerM , SiegfriedN . Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2011, issue 8. [CENTRAL: CD009153] ">Anglemyer 2011b</a>) after the data and safety monitoring board of a trial in progress (<a href="./references#CD009153-bbs2-0002" title="CohenM , ChenY , McCauleyM , et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med2011; Vol. 10.1056/nejmoa1105243. ">Cohen 2011</a>) recommended that its findings be released ahead of schedule. Those findings were included in the review's second version (<a href="./references#CD009153-bbs2-0063" title="AnglemyerA , Rutherford GeorgeW , Baggaley RachelC , EggerM , SiegfriedN . Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2011, issue 8. [CENTRAL: CD009153] ">Anglemyer 2011b</a>). Searches for the review's current version were conducted on August 31, 2012. </p> <p>The searches on February 1, 2011 produced 1,483 titles after 331 duplicates were removed. After initial screening of titles by one author (TH), 237 titles and abstracts were selected for further review by two authors (AA and GWR). AA and GWR independently conducted the selection of potentially relevant studies by scanning the titles, abstracts, and descriptor terms of all downloaded material from the electronic searches. Irrelevant reports were discarded, and the full article was obtained for all potentially relevant or uncertain reports. AA and GWR independently applied the inclusion criteria. NS acted as arbiter where there was disagreement. Studies were reviewed for relevance, based on study design, types of participants, exposures and outcomes measures. Finally, where resolution was not possible because further information was required, the study was allocated to the list of those awaiting assessment. Twenty‐three full‐text articles were closely examined by two authors (AA and GWR). In the review's initial publication (<a href="./references#CD009153-bbs2-0062" title="AnglemyerA , RutherfordGW , EggerM , SiegfriedN . Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples. Cochrane Database of Systematic Reviews 2011 May 11, Issue 5. [CENTRAL: CD009153] ">Anglemyer 2011a</a>), seven observational studies were included. The second version (<a href="./references#CD009153-bbs2-0063" title="AnglemyerA , Rutherford GeorgeW , Baggaley RachelC , EggerM , SiegfriedN . Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2011, issue 8. [CENTRAL: CD009153] ">Anglemyer 2011b</a>) added RCT data from <a href="./references#CD009153-bbs2-0002" title="CohenM , ChenY , McCauleyM , et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med2011; Vol. 10.1056/nejmoa1105243. ">Cohen 2011</a>. It thus included one RCT and seven observational studies. See <a href="#CD009153-fig-0003">Figure 3</a> for a flowchart of the screening process for <a href="./references#CD009153-bbs2-0063" title="AnglemyerA , Rutherford GeorgeW , Baggaley RachelC , EggerM , SiegfriedN . Antiretroviral therapy for prevention of HIV transmission in HIV‐discordant couples. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2011, issue 8. [CENTRAL: CD009153] ">Anglemyer 2011b</a>. </p> <div class="figure" id="CD009153-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Screening process, PREVIOUS version of the review (Anglemyer 2011b)" data-id="CD009153-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Screening process, PREVIOUS version of the review (Anglemyer 2011b)</p> </div> </div> </div> <p>The searches on August 31, 2012 produced 2,350 titles after 720 duplicates were removed. After initial screening of titles by one author (TH), 882 titles and abstracts were selected for further review by two authors (AA and GWR). AA and GWR independently conducted the selection of potentially relevant studies by scanning the titles, abstracts, and descriptor terms of all downloaded material from the electronic searches. Irrelevant reports were discarded, and the full article was obtained for all potentially relevant or uncertain reports. AA and GWR independently applied the inclusion criteria. TH acted as arbiter where there was disagreement. Studies were reviewed for relevance, based on study design, types of participants, exposures and outcomes measures. Finally, where resolution was not possible because further information was required, the study was allocated to the list of those awaiting assessment. Sixty‐four full‐text articles were closely examined by two authors (AA and GWR). Two new cohort studies were identified. In the current review, one RCT and nine cohort studies met our inclusion criteria for data extraction, coding and potential meta‐analysis. See <a href="#CD009153-fig-0004">Figure 4</a> for a flowchart of the screening process for the current review. </p> <div class="figure" id="CD009153-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Screening process, CURRENT version of the review." data-id="CD009153-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Screening process, CURRENT version of the review.</p> </div> </div> </div> </section> <section id="CD009153-sec-0055"> <h4 class="title">Included studies</h4> <p>The RCT was conducted in nine countries: Botswana, Brazil, India, Malawi, Kenya, South Africa, Thailand, United States of America and Zimbabwe (<a href="./references#CD009153-bbs2-0002" title="CohenM , ChenY , McCauleyM , et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med2011; Vol. 10.1056/nejmoa1105243. ">Cohen 2011</a>). This trial mostly included heterosexual partners, but 3% homosexual partners were also included. The nine included cohort studies were conducted in Italy (<a href="./references#CD009153-bbs2-0008" title="MusiccoM , LazzarinA , NicolosiA , GaspariniM , CostigliolaP , AriciC , SaraccoA . Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med1994;154:1971‐1976. ">Musicco 1994</a>), Brazil (<a href="./references#CD009153-bbs2-0007" title="MeloMG , SantosBR , LiraRD , VarellaIS , TurellaML , RochaTM , Nielsen‐SainesK . Sexual Transmission of HIV‐1 Among serodiscordant couples in Porto Alegre, Southern Brazil. Sex Transm Dis2008;35:912‐915. ">Melo 2008</a>), Zambia and Rwanda (<a href="./references#CD009153-bbs2-0010" title="SullivanP , KayitenkoreK , ChombaE , KaritaE , MwananyandaL , VwalikaC , ConklingM , LuisiN , TichacekA , AllenS . Is the reduction of HIV transmission risk while prescribed antiretroviral therapy (ARVT) different for men and women? Results from discordant couples in Rwanda and Zambia.. 5th International AIDS Society Conference on HIV Pathogenesis and Treatment and Prevention. Abstract Number 2009_WEAC101. Cape Town, July 2009. ">Sullivan 2009</a>), Uganda (<a href="./references#CD009153-bbs2-0009" title="ReynoldsS , MakumbiF , NakigoziG , KagaayiJ , GrayR , WawerM , QuinnT , SerwaddaD . HIV‐1 transmission among HIV‐1 discordant couples before and after the introduction of antiretroviral therapy.. AIDS2011;25:473‐477. ">Reynolds 2011</a>, <a href="./references#CD009153-bbs2-0001" title="JBirungi , HWang , MNgolobe , KMuldoon , SKhanakwa , RKing , PKaleebu , KShannon , LLourenco , JMin , JMontaner , EMills , YChen , DMMoore . Lack of Effectiveness of ART as an HIV Prevention Tool for Sero‐discordant Couples in a Rural ART Program in Uganda. XIX International AIDS Conference. July 23‐27, 2012, Washington DC. ">Birungi 2012</a>), Spain (<a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>), China (<a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a>, <a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a>) and Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, and Zambia (<a href="./references#CD009153-bbs2-0004" title="DonnellD , BaetenJ , KiarieJ , ThomasK , StevensW , CohenC , McIntyreJ , LingappaJ , CelumC . Heterosexual HIV‐1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet2010;6736(10):2092‐2098. ">Donnell 2010</a>). Two studies appeared both in abstract and print form (<a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>, <a href="./references#CD009153-bbs2-0004" title="DonnellD , BaetenJ , KiarieJ , ThomasK , StevensW , CohenC , McIntyreJ , LingappaJ , CelumC . Heterosexual HIV‐1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet2010;6736(10):2092‐2098. ">Donnell 2010</a>). Six of the nine observational studies were of partners of persons infected heterosexually (<a href="./references#CD009153-bbs2-0008" title="MusiccoM , LazzarinA , NicolosiA , GaspariniM , CostigliolaP , AriciC , SaraccoA . Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med1994;154:1971‐1976. ">Musicco 1994</a>, <a href="./references#CD009153-bbs2-0010" title="SullivanP , KayitenkoreK , ChombaE , KaritaE , MwananyandaL , VwalikaC , ConklingM , LuisiN , TichacekA , AllenS . Is the reduction of HIV transmission risk while prescribed antiretroviral therapy (ARVT) different for men and women? Results from discordant couples in Rwanda and Zambia.. 5th International AIDS Society Conference on HIV Pathogenesis and Treatment and Prevention. Abstract Number 2009_WEAC101. Cape Town, July 2009. ">Sullivan 2009</a>, <a href="./references#CD009153-bbs2-0004" title="DonnellD , BaetenJ , KiarieJ , ThomasK , StevensW , CohenC , McIntyreJ , LingappaJ , CelumC . Heterosexual HIV‐1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet2010;6736(10):2092‐2098. ">Donnell 2010</a>, <a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a>, <a href="./references#CD009153-bbs2-0009" title="ReynoldsS , MakumbiF , NakigoziG , KagaayiJ , GrayR , WawerM , QuinnT , SerwaddaD . HIV‐1 transmission among HIV‐1 discordant couples before and after the introduction of antiretroviral therapy.. AIDS2011;25:473‐477. ">Reynolds 2011</a>, <a href="./references#CD009153-bbs2-0001" title="JBirungi , HWang , MNgolobe , KMuldoon , SKhanakwa , RKing , PKaleebu , KShannon , LLourenco , JMin , JMontaner , EMills , YChen , DMMoore . Lack of Effectiveness of ART as an HIV Prevention Tool for Sero‐discordant Couples in a Rural ART Program in Uganda. XIX International AIDS Conference. July 23‐27, 2012, Washington DC. ">Birungi 2012</a>), one was of partners in either heterosexual or same‐sex relationships (<a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a>), and two were predominantly of heterosexual partners of injection drug users (<a href="./references#CD009153-bbs2-0007" title="MeloMG , SantosBR , LiraRD , VarellaIS , TurellaML , RochaTM , Nielsen‐SainesK . Sexual Transmission of HIV‐1 Among serodiscordant couples in Porto Alegre, Southern Brazil. Sex Transm Dis2008;35:912‐915. ">Melo 2008</a>, <a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>). In eight observational studies (<a href="./references#CD009153-bbs2-0007" title="MeloMG , SantosBR , LiraRD , VarellaIS , TurellaML , RochaTM , Nielsen‐SainesK . Sexual Transmission of HIV‐1 Among serodiscordant couples in Porto Alegre, Southern Brazil. Sex Transm Dis2008;35:912‐915. ">Melo 2008</a>, <a href="./references#CD009153-bbs2-0010" title="SullivanP , KayitenkoreK , ChombaE , KaritaE , MwananyandaL , VwalikaC , ConklingM , LuisiN , TichacekA , AllenS . Is the reduction of HIV transmission risk while prescribed antiretroviral therapy (ARVT) different for men and women? Results from discordant couples in Rwanda and Zambia.. 5th International AIDS Society Conference on HIV Pathogenesis and Treatment and Prevention. Abstract Number 2009_WEAC101. Cape Town, July 2009. ">Sullivan 2009</a>, <a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>, <a href="./references#CD009153-bbs2-0004" title="DonnellD , BaetenJ , KiarieJ , ThomasK , StevensW , CohenC , McIntyreJ , LingappaJ , CelumC . Heterosexual HIV‐1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet2010;6736(10):2092‐2098. ">Donnell 2010</a>, <a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a>, <a href="./references#CD009153-bbs2-0009" title="ReynoldsS , MakumbiF , NakigoziG , KagaayiJ , GrayR , WawerM , QuinnT , SerwaddaD . HIV‐1 transmission among HIV‐1 discordant couples before and after the introduction of antiretroviral therapy.. AIDS2011;25:473‐477. ">Reynolds 2011</a>, <a href="./references#CD009153-bbs2-0001" title="JBirungi , HWang , MNgolobe , KMuldoon , SKhanakwa , RKing , PKaleebu , KShannon , LLourenco , JMin , JMontaner , EMills , YChen , DMMoore . Lack of Effectiveness of ART as an HIV Prevention Tool for Sero‐discordant Couples in a Rural ART Program in Uganda. XIX International AIDS Conference. July 23‐27, 2012, Washington DC. ">Birungi 2012</a>, <a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a>) infected partners received three or more antiretroviral drugs, and in one early study they received zidovudine (AZT) monotherapy only (<a href="./references#CD009153-bbs2-0008" title="MusiccoM , LazzarinA , NicolosiA , GaspariniM , CostigliolaP , AriciC , SaraccoA . Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med1994;154:1971‐1976. ">Musicco 1994</a>). </p> <p><a href="./references#CD009153-bbs2-0008" title="MusiccoM , LazzarinA , NicolosiA , GaspariniM , CostigliolaP , AriciC , SaraccoA . Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med1994;154:1971‐1976. ">Musicco 1994</a>: Musicco and colleagues conducted a cohort study in Italy, which was published in 1994 in the era before the advent of combination ART. They followed a cohort of 436 monogamous HIV‐uninfected female sexual partners of HIV‐infected men recruited from 16 centres in Italy. Seventy‐nine percent of the male index patients had histories of injection drug use, 25% had symptoms of AIDS, and 48% had fewer than 400 CD4 cells/µL. There were 27 seroconversions observed, 21 in partners of men who were not receiving AZT monotherapy and 6 in partners of men who were. Incidence in the untreated group was 4.4 per 100 person years (95% confidence interval [CI] 2.6‐5.7) and 3.8 (95% CI 1.4‐8.3) in the treated group (unadjusted rate ratio 0.88, 95% CI 0.36‐2.16). However, when adjusted for consistent condom use, presence of p24 antigen, CD4 counts and symptoms of AIDS in infected male partners, the relative risk of female partners of men treated with AZT acquiring HIV was 50% lower (RR 0.5, 95% CI 0.1‐0.9) when compared to female partners of men not treated with AZT. </p> <p><a href="./references#CD009153-bbs2-0007" title="MeloMG , SantosBR , LiraRD , VarellaIS , TurellaML , RochaTM , Nielsen‐SainesK . Sexual Transmission of HIV‐1 Among serodiscordant couples in Porto Alegre, Southern Brazil. Sex Transm Dis2008;35:912‐915. ">Melo 2008</a>: Melo and colleagues followed a cohort of 93 discordant couples in Porto Alegre, Brazil, in which the female member of the couple was infected in 67 (72%) and the male in 26 (28%). Fifteen (58%) of the 26 male and 6 (9%) of the female index cases had histories of injection drug use. Of the 26 male index cases, 5 (19%) had CD4 counts &lt;350 cells/µL; of the 67 female index cases, 3 (5%) had &lt;350 CD4 cells/µL, and 33 (49%) were pregnant at baseline. Comparing treated to untreated serodiscordant couples, their results suggest a protective effect of ART (rate ratio=0.10; 95% CI 0.01‐1.67). </p> <p><a href="./references#CD009153-bbs2-0010" title="SullivanP , KayitenkoreK , ChombaE , KaritaE , MwananyandaL , VwalikaC , ConklingM , LuisiN , TichacekA , AllenS . Is the reduction of HIV transmission risk while prescribed antiretroviral therapy (ARVT) different for men and women? Results from discordant couples in Rwanda and Zambia.. 5th International AIDS Society Conference on HIV Pathogenesis and Treatment and Prevention. Abstract Number 2009_WEAC101. Cape Town, July 2009. ">Sullivan 2009</a>: Sullivan and colleagues presented data from two cohorts of 2,993 HIV‐discordant couples in Rwanda and Zambia followed from 2002 to 2008. No additional background data on cohort members were available from the conference abstract. They observed 175 new infections of which 4 were from partners of index cases on ART. Incidence density was 3.4% per 100 person‐years for those whose partners were not taking ART and 0.7% for those whose partners were taking ART (rate ratio= 0.21, 95% CI 0.08‐0.59). An earlier abstract also reported on this cohort (Kayitenkore 2006). </p> <p><a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>: Del Romero and colleagues analysed data from 648 heterosexual couples attending a clinic in Madrid, Spain, from 1989 to 2008, where uninfected partners were examined for prevalent HIV infection. Five hundred thirty‐five (83%) of the index cases were male and 113 (17%) female. Of the 648 index cases, 494 (76%) had histories of injection drug use. Median CD4 count was 500 cells/µL. Clinical AIDS had been diagnosed at baseline in 107 (17%) of index cases. Forty‐six partners were found to have prevalent HIV infection when examined prior to follow‐up. Forty‐four of these occurred in partners of index cases who had received no ART, and 2 were in partners of index cases who had received either monotherapy or dual therapy. Four hundred twenty‐four serodiscordant couples had follow‐up information collected over 1355 couple years. Five transmission events occurred in untreated couples over 863 couple years, and no transmissions occurred among treated couples over 492 couple years (rate ratio 0.21; 95% CI 0.01‐3.75). Earlier studies also analysed this cohort (<a href="./references#CD009153-bbs2-0029" title="CastillaJ , delRomeroJ , HernandoV , et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr2005;40:96‐101. ">Castilla 2005</a>). </p> <p><a href="./references#CD009153-bbs2-0004" title="DonnellD , BaetenJ , KiarieJ , ThomasK , StevensW , CohenC , McIntyreJ , LingappaJ , CelumC . Heterosexual HIV‐1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet2010;6736(10):2092‐2098. ">Donnell 2010</a>: Donnell and colleagues reported data in an abstract from a prospective cohort analysis of an RCT of heterosexual African adults who were seropositive for both HIV and herpes simplex virus type 2 (HSV‐2) and their HIV‐uninfected sexual partners. Three thousand four hundred eight couples were enrolled from seven countries (Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda and Zambia). Of the 3,381 infected index cases, 2,284 (68%) were female and 1,097 (32%) were male. The median CD4 count of index patients was 462 cells/µL, the median plasma viral load was 4.1 log<sub>10</sub> copies/mL, and 34% of infected male partners and 55% of uninfected male partners were circumcised. One hundred three genetically linked new infections were identified in partners; one was in the partner of a treated index case. The incidence in partners of untreated index cases was 2.24 (1.84‐2.72) per 100 person‐years as compared to 0.37 (95% CI 0.09‐2.04) per 100 person‐years in partners of treated index cases (adjusted incidence rate ratio 0.08, 95% CI 0.00‐0.57). This population was previously analysed in another abstract (<a href="./references#CD009153-bbs2-0032" title="DonnellD , KiarieJ , ThomasK , et al. ART and risk of heterosexual HIV‐1 transmission in HIV‐1 serodiscordant African couples: a multinational prospective study.. 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, 2009. ">Donnell 2009</a>). </p> <p><a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a>: Lu and colleagues analysed data from a prospective cohort study that enrolled 1927 heterosexual couples between January 2006 and December 2008 for testing and treatment at county hospitals in China. Serodiscordant couples were identified through an HIV database and enrolled at local hospitals and health centres. The couples received HIV testing every 6 months and in the event of transmission to an uninfected partner, a recent history of sexual behaviours was taken from the participants. Of the 1927 couples, there were 1092 (57%) HIV‐infected male partners and 835 (43%) HIV‐infected female partners. The last recorded CD4 count was &lt;200 cells/µL for 422 index spouses (23%), and ≥350 cells/µ for 675 (35%) index partners. Approximately 80% of the studied couples were treated with antiretroviral therapy. Eighty‐four (4%) partners seroconverted by the end of follow up, yielding an overall rate of 1.71 per 100 person‐years. There was no relationship between the rate of seroconversion and last CD4 count in the index spouse. There was also no effect of ART on preventing HIV transmission in this study as 4.8% of treated couples and 3.2% of untreated couples seroconverted (yielding a non‐significant rate ratio of 1.44; 95% CI 0.85‐2.44). </p> <p><a href="./references#CD009153-bbs2-0002" title="CohenM , ChenY , McCauleyM , et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med2011; Vol. 10.1056/nejmoa1105243. ">Cohen 2011</a>: This was a Phase III, two‐arm, multicentre RCT that enrolled 1750 serodiscordant heterosexual and male homosexual couples. All index cases had 350‐550 CD4 cells/µL at baseline and were randomly assigned to immediate ART treatment initiation or delayed treatment until two consecutive measurements of 200‐250 CD4 cells/µL or an AIDS defining illness (<a href="./references#CD009153-bbs2-0044" title="HIV Prevention Trials Network. HPTN 052: a randomized trial to evaluate the effectiveness of antiretroviral therapy plus HIV primary care versus HIV primary care alone to prevent the sexual transmission of HIV‐1 serodiscordant couples. HPTN 052 protocol. Available at http://www.hptn.org/research_studies/HPTN052StudyDocuments.asp#Protocol. Accessed 19 May 2011. ">HPTN 2011</a>). No participants had histories of injection drug use. All serodiscordant couples were given prevention and adherence counseling and provided with free condoms. In the immediate treatment arm over 1585 person years, there was one HIV transmission to partner that was linked by virological genomic analysis to that of the index case. In the delayed treatment arm over 1567 person years, there were 27 linked HIV transmissions, yielding a rate ratio of 0.04 (95% CI 0.00‐0.27). When considering all HIV infections, regardless of confirmatory linkages, there were 35 HIV transmissions in the delayed arm and 4 transmissions in the immediate arm (rate ratio 0.11; 95% CI 0.04‐0.32). Subsequent analyses identified 38 cases, from which 29 (76.3%) were definitively linked using a phylogenetic analysis of HIV pol sequences, and in 7 cases (18.4%) the index partner was ruled out as a likely source of HIV infection (<a href="./references#CD009153-bbs2-0034" title="EshlemanS , HudelsonS , ReddA , et al. Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial. The Journal of Infectious Diseases2011;204:1918‐26. ">Eshleman 2011</a>). </p> <p><a href="./references#CD009153-bbs2-0009" title="ReynoldsS , MakumbiF , NakigoziG , KagaayiJ , GrayR , WawerM , QuinnT , SerwaddaD . HIV‐1 transmission among HIV‐1 discordant couples before and after the introduction of antiretroviral therapy.. AIDS2011;25:473‐477. ">Reynolds 2011</a>: Reynolds and colleagues reported data from a cohort of 250 HIV‐discordant couples from Rakai, Uganda. They observed 42 seroconversions over 459 person‐years of exposure to index patients not on ART (incidence 9.2 per 100 person‐years, 95% CI 6.6‐12.4) and none over 53.6 person‐years on ART (rate ratio= 0.10; 95% CI 0.01‐1.64). </p> <p><a href="./references#CD009153-bbs2-0001" title="JBirungi , HWang , MNgolobe , KMuldoon , SKhanakwa , RKing , PKaleebu , KShannon , LLourenco , JMin , JMontaner , EMills , YChen , DMMoore . Lack of Effectiveness of ART as an HIV Prevention Tool for Sero‐discordant Couples in a Rural ART Program in Uganda. XIX International AIDS Conference. July 23‐27, 2012, Washington DC. ">Birungi 2012</a>: Birungi and colleagues examined the effectiveness of ART as prevention in a programmatic setting in rural Uganda without access to viral load testing. The authors enrolled 550 serodiscordant couples and began HAART in 260 couples (CD4 &lt;=250 or WHO stage IV illness) and delayed treatment in 290 couples not yet eligible for ART. All couples were tested every 3 months. Ultimately, 586 couples were enrolled with 348 couples (59%) of the positive participants received ART during the study (249 on ART at enrolment; 99 began ART after enrolment). Median ART‐use at enrolment was 2.5 years among couples treated with ART. Median follow up was 1.3 years for all couples. There were 17 infections diagnosed during the follow‐up (9 infections in the ART group and 8 infections in the non‐ART group). Incidence was estimated as 2.09 infections per 100 person years for the ART group and 2.30 infections per 100 person years for the non‐ART group. The overall incidence rate ratio was 0.91 (95% CI 0.38‐2.20). </p> <p><a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a>: This was a large, national‐level study assessing the effect of antiretroviral therapy on HIV transmission risk among discordant couples across China from January 2003 to December 2011. All HIV‐infected individuals in China who reported having a spouse or regular sex partner were followed by the Chinese Centre for Disease Control and Prevention (China CDC). Every 6 months HIV‐negative partners were tested and HIV‐infected partners received repeat CD4 cell count tests. A total of 24,057 discordant couples were identified for the ART‐treated cohort and 14,805 discordant couples were identified for the ART‐naive cohort and followed over 101,295.1 person‐years. Over all couples, a total of 1631 HIV transmissions occurred for an overall rate of 1.6 transmission per 100 person‐years (95% CI 1.5‐1.7). Among treated couples, the rate was 1.3 per 100 person years (95% CI 1.2‐1.3) and among the untreated couples the transmission rate was 2.6 per 100 person years (95% CI 2.4‐2.8), yielding an unadjusted HR=0.61 (95% CI 0.55‐0.67). After adjusting for duration of follow‐up, sociodemographic variables, route of HIV infection, and baseline CD4 among index cases, the authors estimated a HR=0.74 (95% CI 0.65‐0.84). Considering couples treated with baseline CD4 &lt; 250 compared to couples untreated the unadjusted HR=0.57 (95% CI 0.45‐0.72). Similarly, considering couples treated with baseline CD4 250‐349 compared to couples untreated the unadjusted HR=0.66 (95% CI 0.47‐0.94). Lastly, comparing couples treated with baseline CD4 350 or greater with untreated couples, HR=0.45 (95% CI 0.31‐0.66). </p> </section> <section id="CD009153-sec-0056"> <h4 class="title">Excluded studies</h4> <p>We excluded data from 13 couples transmission studies in which ART was not given (<a href="./references#CD009153-bbs2-0020" title="OperskalskiEA , StramDO , BuschMP , HuangW , HarrisM , DietrichSL , et al. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients.. Am J Epidemiol1997;146:655‐661. ">Operskalski 1997</a>, <a href="./references#CD009153-bbs2-0024" title="RagniMV , FarukiH , KingsleyLA . Heterosexual HIV‐1transmission and viral load in hemophilic patients. J Acquir Immune Defic Syndr Hum Retrovirol1998;17:42‐45. ">Ragni 1998</a>, <a href="./references#CD009153-bbs2-0023" title="QuinnTC , WawerMJ , SewankamboN , et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1.. N Engl J Med2000;342:921‐29. ">Quinn 2000</a>, <a href="./references#CD009153-bbs2-0016" title="FideliUS , AllenSA , MusondaR , TraskS , HahnBH , WeissH , et al. Virologic and immunologic determinants of heterosexual transmission of human immunodefciency virus type 1 in Africa.. AIDS Res Hum Retroviruses2001;17:901‐910. ">Fideli 2001</a>, <a href="./references#CD009153-bbs2-0017" title="GrayRH , WawerMJ , BrookmeyerR , SewankamboNK , SerwaddaD , Wabwire‐MangenF , et al. Probability of HIV‐1 transmission per coital act in monogamous, heterosexual HIV‐1‐discordant couples in Rakai, Uganda.. Lancet2001;357:1149‐53. ">Gray 2001</a>, <a href="./references#CD009153-bbs2-0025" title="TovanabutraS , RobisonV , WongtrakulJ , SennumS , SuriyanonV , KingkeowD , et al. Male viral load and heterosexual transmission of HIV‐1 subtype E in northern Thailand.. J Acquir Immune Defic Syndr2002;29:275‐283. ">Tovanabutra 2002</a> ,<a href="./references#CD009153-bbs2-0013" title="BrillI , MacalusoM , the Rwanda/Zambia HIV Research Group. A SAS program for the computation of seroconversion rates in a prospective study of HIV discordant couples in Lusaka, Zambia [Poster Abstract no. 1130].. 2nd IAS Conference on HIV Pathogenesis and Treatment, Paris, France. 13‐16 July 2003. ">Brill 2003</a>, <a href="./references#CD009153-bbs2-0019" title="MehendaleSM , Kishore KumarB , GhateMV , SahayS , GambleT , GodboleSV , et al. Low HIV incidence in HIV sero‐discordant couples in Pune, India [Abstract no. MoPeC3462]. XV International AIDS Conference, Bangkok, Thailand. 11‐16 2004. ">Mehendale 2004</a>, <a href="./references#CD009153-bbs2-0026" title="WawerMJ , GrayRH , SewankamboNK , SerwaddaD , LiX , LaeyendeckerO , et al. Rates of HIV‐1transmission per coital act by stage of HIV‐1 infection in Rakai, Uganda.. J Infect Dis2005;191:1403‐09. ">Wawer 2005</a>, <a href="./references#CD009153-bbs2-0018" title="KayitenkoreK , BekanB , RufagariJ , Marion‐LandaisS , KaritaE , AllenS . The impact of ART on HIV transmission among HIV serodiscordant couples [Abstract no. MOKC101]. XVI International AIDS Conference, Toronto, Canada. 13‐18 August 2006. ">Kayitenkore 2006</a>, <a href="./references#CD009153-bbs2-0022" title="PetersonL , NandaK , Kofi OpokuB , et al. SAVVY Gel for Prevention of HIV infection in women: a Phase 3, double‐blind, randomised placebo‐controlled trial in Ghana. PLoS ONE2007;2(212):e1312. ">Peterson 2007</a>, <a href="./references#CD009153-bbs2-0021" title="PetersP , ZuluI , KancheyaN , et al. Modified Kigali Combined Staging Predicts Risk of Mortality in HIV‐Infected Adults in Lusaka, Zambia. AIDS Research and Human Retroviruses2008;24(7):919. ">Peters 2008</a>, <a href="./references#CD009153-bbs2-0011" title="BaetenJ , DonnellD , KapigaS , RonaldA , et al. Male circumcision and risk of male‐to‐female HIV‐1 transmission: a multinational prospective study in African HIV‐1 serodiscordant couples. AIDS2010;24:737‐744. ">Baeten 2010</a>) and 3 couples transmission studies in which all index cases received ART (<a href="./references#CD009153-bbs2-0012" title="BarreiroP , delRomeroJ , LealM , et al. Natural pregnancies in HIV‐serodiscordant couples receiving successful antiretroviral therapy.. AIDS2006;20:85‐92. ">Barreiro 2006</a>, <a href="./references#CD009153-bbs2-0014" title="BunnellR , EkwaruJP , SolbergP , et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda.. AIDS2006;20:85‐92. ">Bunnell 2006</a>, <a href="./references#CD009153-bbs2-0015" title="BunnellR , EkwaruJP , KingR , BechangeS , MooreD , KhanaK , et al. 3‐year follow‐up of sexual behavior and HIV transmission risk of persons taking ART in rural Uganda. 15th Conference on Retroviruses and Opportunistic Infections. Boston, USA. 3‐6 February 2008. ">Bunnell 2008</a>). See <a href="#CD009153-sec-0056">Excluded studies</a> for details. </p> </section> </section> <section id="CD009153-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>In addition to Cochrane Collaboration's tool for assessing the risk of bias for each individual study (<a href="./references#CD009153-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons Ltd, 2008. ">Higgins 2008</a>)<b>,</b> we applied the <a href="./references#CD009153-bbs2-0050" title="WellsGA , SheaB , O'ConnellD , PetersonJ , WelchV , LososM , TugwellP . The Newcastle‐Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta‐analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. ">Newcastle‐Ottawa</a> Scale for bias assessment within observational studies to all included observational studies (<a href="./references#CD009153-bbs2-0050" title="WellsGA , SheaB , O'ConnellD , PetersonJ , WelchV , LososM , TugwellP . The Newcastle‐Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta‐analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. ">Newcastle‐Ottawa</a>). The risk of bias for the included observational studies was assessed on the data and outcomes published within the manuscripts. Please see Figure 2 and <a href="./appendices#CD009153-sec-0078">Appendix 3</a> for assessment results from the <a href="./references#CD009153-bbs2-0050" title="WellsGA , SheaB , O'ConnellD , PetersonJ , WelchV , LososM , TugwellP . The Newcastle‐Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta‐analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. ">Newcastle‐Ottawa</a> Scale and Cochrane risk of bias assessments. All observational studies had cohorts that were representative of treated and untreated, serodiscordant couples. Only three out of the nine included observational studies that estimated the effect of ART after adjusting for either age, sex, or frequency of sex among serodiscordant couples. Three of nine observational studies explicitly described complete follow up of the study participants and/or described the characteristics of the participants lost to follow up. </p> <section id="CD009153-sec-0058"> <h4 class="title">Allocation</h4> <p>In the trial randomisation was stratified by site using permuted block randomisation to achieve approximately 1:1 allocation to each treatment group within each site. </p> </section> <section id="CD009153-sec-0059"> <h4 class="title">Blinding</h4> <p>The trial was unblinded.</p> </section> <section id="CD009153-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>There was no evidence of incomplete outcome data from the trial. Three of nine included observational studies discussed either complete follow up of subjects or characteristics of those lost to follow up. </p> </section> <section id="CD009153-sec-0061"> <h4 class="title">Selective reporting</h4> <p>None detected.</p> </section> <section id="CD009153-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>None detected.</p> </section> </section> <section id="CD009153-sec-0063"> <h3 class="title" id="CD009153-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD009153-tbl-0001"><b>Summary of findings for the main comparison</b> Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part A)</a>; <a href="./full#CD009153-tbl-0002"><b>Summary of findings 2</b> Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part B)</a> </p> <p>The single RCT comparing immediately treated serodiscordant couples and delayed treatment couples showed that ART was associated with a significantly decreased risk of HIV transmission (RR 0.04, 95% CI 0.00‐0.27). </p> <p>In eight of the nine cohort studies we analysed, ART was associated with a decreased risk of transmission from infected index cases to uninfected partners, ranging from rate ratios of 0.08 to 0.91. The only cohort study that we identified that did not find this decreased, unadjusted risk was <a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a>, which did not provide person time data needed to calculate a rate ratio. Using the median person time for both treated and untreated groups in <a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a>, the RR comparing treated couples with untreated couples was 1.44 (95% CI 0.85‐2.44). </p> <p><i>Meta‐analysis</i> </p> <p>As there was only a single RCT, we did not combine its results with those of the observational studies. The RR of phylogenetically linked HIV transmissions (where the newly infected partner had a genetically identical strain as the originally infected partner) in this trial was 0.04 (95% CI 0.00‐0.27) (<a href="./references#CD009153-bbs2-0002" title="CohenM , ChenY , McCauleyM , et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med2011; Vol. 10.1056/nejmoa1105243. ">Cohen 2011</a>), yielding a number needed to treat (NNT) of 60. Considering all HIV transmissions to partners (virologically linked and not virologically linked), the RR was 0.11 (95% CI 0.04‐0.32). See <a href="#CD009153-fig-0005">Figure 5</a> and <a href="#CD009153-fig-0006">Figure 6</a>. </p> <div class="figure" id="CD009153-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.1 Linked Incident HIV Infection." data-id="CD009153-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.1 Linked Incident HIV Infection. </p> </div> </div> </div> <div class="figure" id="CD009153-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.2 All Incident HIV Infection." data-id="CD009153-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.2 All Incident HIV Infection. </p> </div> </div> </div> <p>We performed a meta‐analysis of the nine identified observational studies to estimate the effect of ART on HIV incidence reduction for partners of infected spouses. The summary rate ratio for all nine studies was 0.58 [95% CI 0.35, 0.96], with substantial heterogeneity (I<sup>2</sup>=64%) (see <a href="#CD009153-fig-0007">Figure 7</a>). The ten studies (9 observational studies and 1 RCT) identified 2112 episodes of HIV transmission, 1016 among treated couples and 1096 among untreated couples. To explore the potential influence of the study without adequate person time data (<a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a>) or monotherapy (<a href="./references#CD009153-bbs2-0008" title="MusiccoM , LazzarinA , NicolosiA , GaspariniM , CostigliolaP , AriciC , SaraccoA . Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med1994;154:1971‐1976. ">Musicco 1994</a>), we performed a sensitivity analysis removing the results of these studies. The meta‐analysis of the remaining seven studies yielded a rate ratio of 0.36 [95% CI 0.17, 0.75] with substantial heterogeneity (I<sup>2</sup>=62%) (see <a href="#CD009153-fig-0008">Figure 8</a>). Furthermore, we analysed the remaining seven studies with a fixed‐effects model to see if there was any consistency between the two approaches. The fixed‐effects model yielded a higher rate ratio and narrower confidence interval [RR=0.71; 95% CI 0.63‐0.81]. </p> <div class="figure" id="CD009153-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Treated with ART vs Not Treated with ART (Observational Studies), outcome: 2.1 Incident HIV Infection." data-id="CD009153-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Treated with ART vs Not Treated with ART (Observational Studies), outcome: 2.1 Incident HIV Infection. </p> </div> </div> </div> <div class="figure" id="CD009153-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 3 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), outcome: 3.1 Incident HIV Infection." data-id="CD009153-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 3 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), outcome: 3.1 Incident HIV Infection. </p> </div> </div> </div> <p>We also performed subgroup analyses to see if the effect of ART on prevention of HIV differed by the level of CD4 in the index partner (see <a href="#CD009153-fig-0009">Figure 9</a>). Specifically, we categorised CD4 into three groups‐‐ &lt;200 cells/µ, 200‐349 cells/µL, and ≥350 cells/µL. Five studies had data available for subjects whose CD4 was less than 200 cells/µL (<a href="./references#CD009153-bbs2-0007" title="MeloMG , SantosBR , LiraRD , VarellaIS , TurellaML , RochaTM , Nielsen‐SainesK . Sexual Transmission of HIV‐1 Among serodiscordant couples in Porto Alegre, Southern Brazil. Sex Transm Dis2008;35:912‐915. ">Melo 2008</a>, <a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>, <a href="./references#CD009153-bbs2-0004" title="DonnellD , BaetenJ , KiarieJ , ThomasK , StevensW , CohenC , McIntyreJ , LingappaJ , CelumC . Heterosexual HIV‐1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet2010;6736(10):2092‐2098. ">Donnell 2010</a>, <a href="./references#CD009153-bbs2-0009" title="ReynoldsS , MakumbiF , NakigoziG , KagaayiJ , GrayR , WawerM , QuinnT , SerwaddaD . HIV‐1 transmission among HIV‐1 discordant couples before and after the introduction of antiretroviral therapy.. AIDS2011;25:473‐477. ">Reynolds 2011</a>, <a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a>), four studies had data for subjects whose CD4 was 200‐349 cells/µL (<a href="./references#CD009153-bbs2-0007" title="MeloMG , SantosBR , LiraRD , VarellaIS , TurellaML , RochaTM , Nielsen‐SainesK . Sexual Transmission of HIV‐1 Among serodiscordant couples in Porto Alegre, Southern Brazil. Sex Transm Dis2008;35:912‐915. ">Melo 2008</a>, <a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>, <a href="./references#CD009153-bbs2-0004" title="DonnellD , BaetenJ , KiarieJ , ThomasK , StevensW , CohenC , McIntyreJ , LingappaJ , CelumC . Heterosexual HIV‐1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet2010;6736(10):2092‐2098. ">Donnell 2010</a>, <a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a>), and four studies had data for subjects whose CD4 was ≥350 cells/µ (<a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>, <a href="./references#CD009153-bbs2-0004" title="DonnellD , BaetenJ , KiarieJ , ThomasK , StevensW , CohenC , McIntyreJ , LingappaJ , CelumC . Heterosexual HIV‐1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet2010;6736(10):2092‐2098. ">Donnell 2010</a>, <a href="./references#CD009153-bbs2-0002" title="CohenM , ChenY , McCauleyM , et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med2011; Vol. 10.1056/nejmoa1105243. ">Cohen 2011</a>, <a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a>). The subgroup analysis of studies with patients with &lt;200 cells/µL yielded a rate ratio of 0.12 [95% CI 0.02, 0.81] with substantial heterogeneity (I<sup>2</sup>=71%). The subgroup analysis of studies with patients with 200‐349 cells/µL yielded a rate ratio of 0.66 [95% CI 0.47, 0.92] with no heterogeneity (I<sup>2</sup>=0%). All patients in the RCT had ≥350 CD4 cells/µL at assignment. As noted above, that study found a rate ratio of 0.04 (95% CI 0.00‐0.27). In the three observational studies, we estimated a rate ratio of 0.12 [95% CI 0.01, 1.99] from the subgroup analysis of observational studies with patients with ≥350 cells/µL. Excluding the RCT, in this subgroup the total number of HIV transmissions was 277, with 247 cases among untreated couples. In the observational studies, tests for interaction between the CD4 subgroups were performed and yielded no statistically significant difference between groups. Specifically, the test for interaction between the &lt;200 cells/µL group and the group with 200‐349 cells/µL yielded an RRR of 0.18 (95% CI 0.03‐1.19). Further, when comparing the &lt;200 cells/µL group with the ≥350 cells/µ group, the test for interaction yielded an RRR of 1.00 (95% CI 0.04‐25.27). Finally, a test for interaction between the group with 200‐349 cells/µL and the ≥350 cells/µ group yielded an RRR of 5.50 (95% CI 0.38‐79.25). </p> <div class="figure" id="CD009153-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 3 Treated with ART vs Not Treated with ART (&lt; 200, 200‐350, and &gt; 350 CD4 Subgroup Analysis) (Observational Studies), outcome: 3.1 Incident HIV Infection." data-id="CD009153-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 3 Treated with ART vs Not Treated with ART (&lt; 200, 200‐350, and &gt; 350 CD4 Subgroup Analysis) (Observational Studies), outcome: 3.1 Incident HIV Infection. </p> </div> </div> </div> <p>Additionally, we performed a subgroup analysis of the effect of ART on HIV prevention by the gender of the index case (see <a href="#CD009153-fig-0010">Figure 10</a>). Only three observational studies provided enough data to analyse this subgroup (<a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>, <a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a>, and <a href="./references#CD009153-bbs2-0010" title="SullivanP , KayitenkoreK , ChombaE , KaritaE , MwananyandaL , VwalikaC , ConklingM , LuisiN , TichacekA , AllenS . Is the reduction of HIV transmission risk while prescribed antiretroviral therapy (ARVT) different for men and women? Results from discordant couples in Rwanda and Zambia.. 5th International AIDS Society Conference on HIV Pathogenesis and Treatment and Prevention. Abstract Number 2009_WEAC101. Cape Town, July 2009. ">Sullivan 2009</a>). A summary estimate of the effect of ART on incident HIV among female index cases showed a non‐significant trend toward a reduction of risk when compared to untreated female index cases (relative risk=0.39; 95% 0.13‐1.18). Similarly, if a treated man was the index case, the risk of transmission was not significantly lower when compared to untreated index male cases (relative risk=0.11; 95% CI 0.01‐1.62). Tests for interaction showed no statistically significant difference between index case subgroups (RRR=3.55, 95% CI 0.22‐56.73). </p> <div class="figure" id="CD009153-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 5 Treated with ART vs Not Treated with ART (Female/Male Subgroup Analysis) (Observational Studies), outcome: 5.1 Incident HIV Infection." data-id="CD009153-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 5 Treated with ART vs Not Treated with ART (Female/Male Subgroup Analysis) (Observational Studies), outcome: 5.1 Incident HIV Infection. </p> </div> </div> </div> <p>We also performed a subgroup analysis within the nine observational studies of the effect of ART on HIV prevention by income level of the country (see <a href="#CD009153-fig-0011">Figure 11</a>). Specifically, the effect of ART on HIV prevention in low‐ and middle‐income countries was estimated as RR=0.53 [95% CI 0.29, 0.97] with significant heterogeneity (I<sup>2</sup>=72%). The effect of ART on HIV prevention in high‐income countries was estimated as RR=0.77 [95% CI 0.33, 1.83] with low heterogeneity (I<sup>2</sup>=0%). Again, tests for interaction yielded no statistically significant difference between subgroups of income level (RRR=0.69, 95% CI 0.24‐1.96). </p> <div class="figure" id="CD009153-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 5 Treated with ART vs Not Treated with ART (Subgroup Analysis: LMIC) (Observational Studies), outcome: 5.1 Incident HIV Infection." data-id="CD009153-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 5 Treated with ART vs Not Treated with ART (Subgroup Analysis: LMIC) (Observational Studies), outcome: 5.1 Incident HIV Infection. </p> </div> </div> </div> <p>Severe adverse events (SAEs) have been reported from the RCT. SAEs were not frequently reported in the observational studies. <a href="./references#CD009153-bbs2-0002" title="CohenM , ChenY , McCauleyM , et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med2011; Vol. 10.1056/nejmoa1105243. ">Cohen 2011</a> report that 14% of participants in both the delayed treatment arm and the early treatment arm had one or more severe or life‐threatening events (Grade 3 or 4), suggesting no increased risk between study arms (RR=1.06; 95% CI 0.84‐1.33) (see <a href="#CD009153-fig-0012">Figure 12</a>). The most frequent SAEs were infections, gastrointestinal disorders, metabolic and nutritional disorders and psychiatric and nervous system disorders. In contrast, Grade 3 or 4 laboratory abnormalities, which most often included neutropenia, abnormal phosphate levels and total bilirubin elevations, were more likely found among participants receiving therapy early (27%) when compared to participants receiving delayed treatment (18%) (RR=1.49; 95% CI 1.25‐1.77) (see <a href="#CD009153-fig-0013">Figure 13</a>). Among the observational studies, <a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a> reported that genitourinary infections occurred in 8/144 treated couples (6%) and 62/388 among untreated couples (16%) during follow up. <a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a> reported that 266 (19%) of 1369 treated couples switched ARTs. Nearly all couples who switched (n=259; 97%) did so as a result of adverse events, while three other patients developed resistance. </p> <div class="figure" id="CD009153-fig-0012"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 12</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.3 Severe or Life‐Threatening Adverse Events (Grade 3 or 4)." data-id="CD009153-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG12.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.3 Severe or Life‐Threatening Adverse Events (Grade 3 or 4). </p> </div> </div> </div> <div class="figure" id="CD009153-fig-0013"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 13</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.4 Grade 3 or 4 Laboratory Abnormalities." data-id="CD009153-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG13.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.4 Grade 3 or 4 Laboratory Abnormalities. </p> </div> </div> </div> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009153-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009153-sec-0064"></div> <section id="CD009153-sec-0065"> <h3 class="title" id="CD009153-sec-0065">Summary of main results</h3> <p>We found that ART was associated with decreased risk of transmission of HIV in discordant couples. This intervention effect was particularly pronounced in the one large multicentre RCT that has been completed but also appeared in several observational studies that had adjusted for a variety of cofactors for transmission. Interestingly, the largely historical analyses of <a href="./references#CD009153-bbs2-0008" title="MusiccoM , LazzarinA , NicolosiA , GaspariniM , CostigliolaP , AriciC , SaraccoA . Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med1994;154:1971‐1976. ">Musicco 1994</a> and <a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a> of patients on monotherapy and dual therapy even found pronounced independent protective effects for ART. More recent observational studies, such as <a href="./references#CD009153-bbs2-0010" title="SullivanP , KayitenkoreK , ChombaE , KaritaE , MwananyandaL , VwalikaC , ConklingM , LuisiN , TichacekA , AllenS . Is the reduction of HIV transmission risk while prescribed antiretroviral therapy (ARVT) different for men and women? Results from discordant couples in Rwanda and Zambia.. 5th International AIDS Society Conference on HIV Pathogenesis and Treatment and Prevention. Abstract Number 2009_WEAC101. Cape Town, July 2009. ">Sullivan 2009</a>, <a href="./references#CD009153-bbs2-0004" title="DonnellD , BaetenJ , KiarieJ , ThomasK , StevensW , CohenC , McIntyreJ , LingappaJ , CelumC . Heterosexual HIV‐1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet2010;6736(10):2092‐2098. ">Donnell 2010</a>, and <a href="./references#CD009153-bbs2-0009" title="ReynoldsS , MakumbiF , NakigoziG , KagaayiJ , GrayR , WawerM , QuinnT , SerwaddaD . HIV‐1 transmission among HIV‐1 discordant couples before and after the introduction of antiretroviral therapy.. AIDS2011;25:473‐477. ">Reynolds 2011</a>, have found even larger effects than these earlier studies, suggesting that more potent ART regimens are associated with even greater reductions in transmission, though <a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a> and <a href="./references#CD009153-bbs2-0001" title="JBirungi , HWang , MNgolobe , KMuldoon , SKhanakwa , RKing , PKaleebu , KShannon , LLourenco , JMin , JMontaner , EMills , YChen , DMMoore . Lack of Effectiveness of ART as an HIV Prevention Tool for Sero‐discordant Couples in a Rural ART Program in Uganda. XIX International AIDS Conference. July 23‐27, 2012, Washington DC. ">Birungi 2012</a> found less pronounced reductions in transmission. Only one observational study found an increased risk, albeit statistically non‐significant, of HIV transmission among ART treated couples compared to untreated couples (<a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a>). The authors' study objective was not to examine the effect of ART in serodiscordant couples but rather to estimate HIV incidence and clinical progression, quality of life and behavioural risk factors. Unpublished data suggest that the treated couples were followed for nearly three times longer than untreated couples (3532 years and 1385 years, respectively), thus, possibly allowing for more opportunity for infection among the treated couples. Nevertheless, it should be noted that the authors found no difference in rates of HIV transmission between ART‐treated couples (4.8%) and untreated couples (3.2%). A later analysis, also from China (<a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a>), did find a statistically significant decreased risk of transmission in treated couples compared to untreated couples. It should be noted that <a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a> reported on all serodiscordant couples in China who test HIV‐positive at the National Center for AIDS/STD Control and Prevention at the Chinese Center for Disease Control and Prevention from 2003‐2011, while <a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a> reported on serodiscordant couples reporting to a local subsidiary office of the National Center for AIDS/STD Control and Prevention from 2006‐2008. As such, it is likely that <a href="./references#CD009153-bbs2-0005" title="JiaZ , RuanY , LiQ , XieP , LiP , WangX , ChenRY , ShaoY . Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003‐11): a national observational cohort study. Lancet2012;pii: S0140‐6736(12)61898‐4:[Epub ahead of print]. ">Jia 2012</a> has re‐analyzed some of the same serodiscordant couples as <a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a>, another possibility we considered when performing the sensitivity analysis by removing <a href="./references#CD009153-bbs2-0006" title="LuWang , ZengGe , JingLuo , DuoShan , XingGao , Guo‐weiDing , Jian‐pingZhou , Wen‐shengHe , NingWang . HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China.. JAIDS2010;55:232‐238. ">Lu 2010</a> data from our overall effect. </p> <p>We explored the effect of ART on transmission risk of HIV in discordant couples in CD4 subgroup analyses to see if the effect differed by CD4 stratum. Unfortunately, most observational studies did not report risk of HIV transmission stratified by the index case's baseline CD4. Data from HPTN 052 clearly demonstrate the large and positive benefit among index partners with between 350 and 550 CD4 cells/µL (<a href="./references#CD009153-bbs2-0040" title="GrinsztejnB , SmeatonL , BarnettR , KlingmanK , HakimJ , FlaniganT , KumarasamyN , CampbellT , CurrierJ , PEARLS study team of the ACTG. Sex‐associated differences in pre‐antiretroviral therapy plasma HIV‐1 RNA in diverse areas of the world vary by CD4(+) T‐cell count. Antiviral Therapy2011;16(7):1057‐62. ">Grinsztejn 2011</a>). </p> <p>It is important to note that participants in this study were long‐term couples, and, as such, they do not represent all situations in which transmission risk exists. Transmission during the acute phase of HIV infection is an important contributor to overall incidence (<a href="./references#CD009153-bbs2-0048" title="MillerWC , RosenbergNE , RutsteinSE , PowersKA . Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS2010;5:277‐82. ">Miller 2010</a>) and would not be averted by the couples counseling and partner therapy discussed in this review. </p> <p>Several relevant studies are in progress. Please see <a href="./appendices#CD009153-sec-0079">Appendix 4</a>. </p> </section> <section id="CD009153-sec-0066"> <h3 class="title" id="CD009153-sec-0066">Overall completeness and applicability of evidence</h3> <p>HPTN 052 provides clear and compelling evidence of benefit for treating index participants with between 350 and 550 CD4 cells/µL. Other data we examined that bear on the benefit of therapy are from partnerships where the index participants had &lt;350 CD4 cells/µL, and unmeasured confounding remains a significant issue in these cohort studies. Given that we did not conduct an individual patient database meta‐analysis for the observational studies, we were unable to control for a variety of cofactors, such as number of exposures, circumcision, HIV viral load, sexually transmitted infections, condom use or potency of ART. Nonetheless, the strength and consistency of the evidence and the evidence contributed by the large, high‐quality RCT argue strongly in favour of a potent biological effect of ART on reducing risk of HIV transmission in discordant couples. </p> <p>We found no studies that explored outcomes such as the acquisition of primary drug resistant HIV by previously uninfected partners, HIV‐related mortality, HIV‐related morbidity and quality of life, although subsequent publications from the HPTN 052 trial will likely shed light on these outcomes. Because the vast majority of the couples in the included studies were heterosexual, the findings of this review may not be generalisable to populations of men who have sex with men. Other concerns that must be addressed are the additional financial costs of recommending ART for prevention, which would make implementation difficult if not impossible in many resource‐constrained settings. There is also the potential for significant implementation and adherence challenges if ART is offered earlier to discordant couples (e.g., expanding treatment indications) when large numbers of patients that meet clinical or immunologic criteria for treatment are remain untreated. </p> </section> <section id="CD009153-sec-0067"> <h3 class="title" id="CD009153-sec-0067">Quality of the evidence</h3> <p><b>GRADE</b> </p> <p>In the GRADE system, well‐conducted RCTs (without additional limitations) provide high quality evidence, and observational studies without any special strengths (and without additional limitations) provide low‐quality evidence. The quality of evidence provided by a body of literature comprised exclusively of observational studies would thus be graded as "low." In this analysis, we found that the quality of evidence was high, based on the large effect size found in the RCT, the biological plausibility of the relationship and the strength, temporality and the consistency of this relationship in the supporting observational studies. Please see <a href="./full#CD009153-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD009153-tbl-0002">summary of findings Table 2</a> for details. </p> </section> <section id="CD009153-sec-0068"> <h3 class="title" id="CD009153-sec-0068">Potential biases in the review process</h3> <p>Biases in the review process were minimised by not limiting the search by language, by performing a comprehensive search of databases and conference proceedings and by contacting experts in the field for unpublished and ongoing studies. We explored publication bias for the observational studies by using funnel plots (see <a href="#CD009153-fig-0014">Figure 14</a> and <a href="#CD009153-fig-0015">Figure 15</a>). Based on only nine studies, it is difficult to adequately assess publication bias. However, <a href="#CD009153-fig-0014">Figure 14</a> may suggest publication bias, but the assymetry in the plot could also be an artefact of the true effect size differences between high precision studies and low precision studies. Furthermore, RR data were not available for all studies, which in turn could have influenced these estimated effect sizes. </p> <div class="figure" id="CD009153-fig-0014"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 14</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Treated with ART vs Not Treated with ART (Observational Studies), outcome: 2.1 Incident HIV Infection." data-id="CD009153-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG14.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Treated with ART vs Not Treated with ART (Observational Studies), outcome: 2.1 Incident HIV Infection. </p> </div> </div> </div> <div class="figure" id="CD009153-fig-0015"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 15</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), outcome: 3.1 Incident HIV Infection." data-id="CD009153-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG15.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), outcome: 3.1 Incident HIV Infection. </p> </div> </div> </div> </section> <section id="CD009153-sec-0069"> <h3 class="title" id="CD009153-sec-0069">Agreements and disagreements with other studies or reviews</h3> <p>Our findings are consistent with those of another recent review (<a href="./references#CD009153-bbs2-0028" title="AttiaS , EggerM , MullerM , ZwahlenM , LowN . Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta‐analysis. AIDS2009;23:1397‐1404. ">Attia 2009</a>). </p> <p>The review by Attia and colleagues (<a href="./references#CD009153-bbs2-0028" title="AttiaS , EggerM , MullerM , ZwahlenM , LowN . Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta‐analysis. AIDS2009;23:1397‐1404. ">Attia 2009</a>) was focused differently than ours.  The objective of <a href="./references#CD009153-bbs2-0028" title="AttiaS , EggerM , MullerM , ZwahlenM , LowN . Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta‐analysis. AIDS2009;23:1397‐1404. ">Attia 2009</a> was to estimate HIV transmission rates among serodiscordant couples with various treatment experience, while our review’s objective is to estimate the pooled risk of transmission, comparing ART‐treated couples with ART‐untreated couples. <a href="./references#CD009153-bbs2-0028" title="AttiaS , EggerM , MullerM , ZwahlenM , LowN . Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta‐analysis. AIDS2009;23:1397‐1404. ">Attia 2009</a> includes three types of studies: a) studies of only ART‐treated couples, b) studies of only untreated couples, and c) studies of both ART‐treated and untreated couples.  Our review includes only studies with both ART‐treated and untreated couples. Four of the studies identified in our review were also included in <a href="./references#CD009153-bbs2-0028" title="AttiaS , EggerM , MullerM , ZwahlenM , LowN . Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta‐analysis. AIDS2009;23:1397‐1404. ">Attia 2009</a>: <a href="./references#CD009153-bbs2-0029" title="CastillaJ , delRomeroJ , HernandoV , et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr2005;40:96‐101. ">Castilla 2005</a> (<a href="./references#CD009153-bbs2-0003" title="DelRomeroJ , CastillaJ , HernandoV , RodriguezC , GarciaS . Combined antiretroviral treatment and heterosexual transmission of HIV‐1: cross sectional and prospective cohort study.. BMJ2010;340:c2205. ">Del Romero 2010</a>), <a href="./references#CD009153-bbs2-0007" title="MeloMG , SantosBR , LiraRD , VarellaIS , TurellaML , RochaTM , Nielsen‐SainesK . Sexual Transmission of HIV‐1 Among serodiscordant couples in Porto Alegre, Southern Brazil. Sex Transm Dis2008;35:912‐915. ">Melo 2008</a>, <a href="./references#CD009153-bbs2-0009" title="ReynoldsS , MakumbiF , NakigoziG , KagaayiJ , GrayR , WawerM , QuinnT , SerwaddaD . HIV‐1 transmission among HIV‐1 discordant couples before and after the introduction of antiretroviral therapy.. AIDS2011;25:473‐477. ">Reynolds 2011</a>, and <a href="./references#CD009153-bbs2-0010" title="SullivanP , KayitenkoreK , ChombaE , KaritaE , MwananyandaL , VwalikaC , ConklingM , LuisiN , TichacekA , AllenS . Is the reduction of HIV transmission risk while prescribed antiretroviral therapy (ARVT) different for men and women? Results from discordant couples in Rwanda and Zambia.. 5th International AIDS Society Conference on HIV Pathogenesis and Treatment and Prevention. Abstract Number 2009_WEAC101. Cape Town, July 2009. ">Sullivan 2009</a>. No formal assessment of evidence quality was performed in <a href="./references#CD009153-bbs2-0028" title="AttiaS , EggerM , MullerM , ZwahlenM , LowN . Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta‐analysis. AIDS2009;23:1397‐1404. ">Attia 2009</a>. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009153-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009153-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Newcastle‐Ottawa Scale for Bias Assessment" data-id="CD009153-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Newcastle‐Ottawa Scale for Bias Assessment</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Screening process, PREVIOUS version of the review (Anglemyer 2011b)" data-id="CD009153-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Screening process, PREVIOUS version of the review (Anglemyer 2011b)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Screening process, CURRENT version of the review." data-id="CD009153-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Screening process, CURRENT version of the review.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.1 Linked Incident HIV Infection." data-id="CD009153-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.1 Linked Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.2 All Incident HIV Infection." data-id="CD009153-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.2 All Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Treated with ART vs Not Treated with ART (Observational Studies), outcome: 2.1 Incident HIV Infection." data-id="CD009153-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Treated with ART vs Not Treated with ART (Observational Studies), outcome: 2.1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 3 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), outcome: 3.1 Incident HIV Infection." data-id="CD009153-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 3 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), outcome: 3.1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 3 Treated with ART vs Not Treated with ART (&lt; 200, 200‐350, and &gt; 350 CD4 Subgroup Analysis) (Observational Studies), outcome: 3.1 Incident HIV Infection." data-id="CD009153-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot of comparison: 3 Treated with ART vs Not Treated with ART (&lt; 200, 200‐350, and &gt; 350 CD4 Subgroup Analysis) (Observational Studies), outcome: 3.1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 5 Treated with ART vs Not Treated with ART (Female/Male Subgroup Analysis) (Observational Studies), outcome: 5.1 Incident HIV Infection." data-id="CD009153-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Forest plot of comparison: 5 Treated with ART vs Not Treated with ART (Female/Male Subgroup Analysis) (Observational Studies), outcome: 5.1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG11.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 5 Treated with ART vs Not Treated with ART (Subgroup Analysis: LMIC) (Observational Studies), outcome: 5.1 Incident HIV Infection." data-id="CD009153-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Forest plot of comparison: 5 Treated with ART vs Not Treated with ART (Subgroup Analysis: LMIC) (Observational Studies), outcome: 5.1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG12.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.3 Severe or Life‐Threatening Adverse Events (Grade 3 or 4)." data-id="CD009153-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.3 Severe or Life‐Threatening Adverse Events (Grade 3 or 4). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG13.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.4 Grade 3 or 4 Laboratory Abnormalities." data-id="CD009153-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Delayed vs Immediate ART (RCTs), outcome: 1.4 Grade 3 or 4 Laboratory Abnormalities. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG14.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Treated with ART vs Not Treated with ART (Observational Studies), outcome: 2.1 Incident HIV Infection." data-id="CD009153-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 14</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Treated with ART vs Not Treated with ART (Observational Studies), outcome: 2.1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-AFig-FIG15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-AFig-FIG15.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), outcome: 3.1 Incident HIV Infection." data-id="CD009153-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 15</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), outcome: 3.1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-AFig-FIG15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Delayed vs Immediate ART (RCTs), Outcome 1 Linked Incident HIV Infection." data-id="CD009153-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Delayed vs Immediate ART (RCTs), Outcome 1 Linked Incident HIV Infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Delayed vs Immediate ART (RCTs), Outcome 2 All Incident HIV Infection." data-id="CD009153-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Delayed vs Immediate ART (RCTs), Outcome 2 All Incident HIV Infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Delayed vs Immediate ART (RCTs), Outcome 3 Severe or Life‐Threatening Adverse Events (Grade 3 or 4)." data-id="CD009153-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Delayed vs Immediate ART (RCTs), Outcome 3 Severe or Life‐Threatening Adverse Events (Grade 3 or 4). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Delayed vs Immediate ART (RCTs), Outcome 4 Grade 3 or 4 Laboratory Abnormalities." data-id="CD009153-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Delayed vs Immediate ART (RCTs), Outcome 4 Grade 3 or 4 Laboratory Abnormalities.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Treated with ART vs Not Treated with ART (Observational Studies), Outcome 1 Incident HIV Infection." data-id="CD009153-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Treated with ART vs Not Treated with ART (Observational Studies), Outcome 1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-CMP-003-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), Outcome 1 Incident HIV Infection." data-id="CD009153-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis), Outcome 1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-CMP-004-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Treated with ART vs Not Treated with ART (&lt; 200, 200‐349, and ≥350 CD4 Cells/µL Subgroup Analysis) (Observational Studies), Outcome 1 Incident HIV Infection." data-id="CD009153-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Treated with ART vs Not Treated with ART (&lt; 200, 200‐349, and ≥350 CD4 Cells/µL Subgroup Analysis) (Observational Studies), Outcome 1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-CMP-005-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Treated with ART vs Not Treated with ART (Female/Male Subgroup Analysis) (Observational Studies), Outcome 1 Incident HIV Infection." data-id="CD009153-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Treated with ART vs Not Treated with ART (Female/Male Subgroup Analysis) (Observational Studies), Outcome 1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009153-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/urn:x-wiley:14651858:media:CD009153:CD009153-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_t/tCD009153-CMP-006-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Treated with ART vs Not Treated with ART (Subgroup Analysis: Low‐/Middle‐Income vs High‐income)) (Observational Studies), Outcome 1 Incident HIV Infection." data-id="CD009153-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Treated with ART vs Not Treated with ART (Subgroup Analysis: Low‐/Middle‐Income vs High‐income)) (Observational Studies), Outcome 1 Incident HIV Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/media/CDSR/CD009153/image_n/nCD009153-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009153-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part A)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part A)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Serodiscordant couples <br/> <b>Settings:</b> Botswana, Brazil, China, India, Italy Malawi, Kenya, Rwanda, South Africa, Spain, Thailand, Uganda, United States of America, Zambia and Zimbabwe <br/> <b>Intervention:</b> Antiretroviral Therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antiretroviral therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Virologically linked HIV incidence (RCT)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>17 per 1000</b><sup>5,8</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>1 per 1000</b> </p> <p>(0 to 5)<sup>5,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rate Ratio 0.04</b> <br/> (0.00 to 0.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1750</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕ <br/> <b>high</b><sup>5,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence (observational studies)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b> <br/> (19 to 51)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate Ratio 0.58</b> <br/> (0.35 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46204 <br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence (observational studies‐‐sensitivity analysis)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b> <br/> (8 to 36)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate Ratio 0.36</b> <br/> (0.17 to 0.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46560 <br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: CD4 subgroups (&lt;200 cells/µL) (observational studies)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b><sup>2,6</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 1000</b> <br/> (1 to 39)<sup>2,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.12</b> <br/> (0.02 to 0.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26594 <br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>5,7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: CD4 subgroups (200‐350 CD4 cells/µL) (observational studies)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 1000</b><sup>2,6</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (13 to 26)<sup>2,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.66</b> <br/> (0.47 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9595 <br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>3,8,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: CD4 subgroups (350 or more CD4 cells/µL) (observational studies)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 1000</b><sup>2,6</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> <br/> (0 to 49)<sup>2,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.12</b> <br/> (0.01 to 1.99.) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13426 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>5,8,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Virologically linked HIV incidence: CD4 subgroups (350 or more CD4 cells/µL) (RCT)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>17 per 1000<sup>5,8</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>1 per 1000</p> <p>(0 to 5)<sup>5,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.04</b> <br/> (0.00 to 0.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1750</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕ <br/> <b>high</b><sup>5,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>RCT:</b> randomised controlled trial; <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Less than 5% of sample was imputed due to missing information in the denominator. <br/> <sup>2</sup> Numerators and Denominators taken from text where possible. Numbers were not used to calculate the relative effect estimates. <br/> <sup>3</sup> Rate Ratio ˜ 0.50 <br/> <sup>4</sup> Two studies were removed due to differences in intervention or incomplete data. <br/> <sup>5</sup> RR &lt; 0.35 <br/> <sup>6</sup> Due to missing information in the denominator and/or numerator, some data were imputed from text. <br/> <sup>7</sup> No person time available for 3 out of 5 studies. <br/> <sup>8</sup> Few events and/or wide confidence interval. <br/> <sup>9</sup> No person time available for 2 out of 4 studies. <br/> <sup>10</sup> No person time available for 1 out of 3 studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part A)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009153-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part B)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part B)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Serodiscordant couples <br/> <b>Settings:</b> Botswana, Brazil, China, Italy, Kenya, Rwanda, South Africa, Spain, Tanzania, Uganda, and Zambia <br/> <b>Intervention:</b> Antiretroviral Therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antiretroviral therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: gender subgroup (female cases)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (10 to 88)<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.39</b> <br/> (0.13 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15608 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational studies only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: gender subgroup (male Cases)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b> <br/> (0 to 78)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.11</b> <br/> (0.01 to 1.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25073 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational studies only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: low‐/middle‐income countries</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (16 to 53)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.53</b> <br/> (0.29 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45029 <br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝ <br/> <b>low</b><sup>3,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational studies only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HIV incidence: high income countries</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b><sup>1,2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b> <br/> (10 to 57)<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b> <br/> (0.33 to 1.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1061 <br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Observational studies only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Numerators and denominators taken from text where possible. Numbers were not used to calculate the relative effect estimates. <br/> <sup>2</sup> Due to missing information in the denominator and/or numerator, some data were imputed from text. <br/> <sup>3</sup> Few events and/or wide confidence interval. <br/> <sup>4</sup> RR ˜ 0.35 <br/> <sup>5</sup> Rate Ratio ˜ 0.50 </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antiretroviral Therapy for HIV Prevention in Serodiscordant Couples (Part B)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/full#CD009153-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009153-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Delayed vs Immediate ART (RCTs)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Linked Incident HIV Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.00, 0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 All Incident HIV Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.04, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Severe or Life‐Threatening Adverse Events (Grade 3 or 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1763</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.84, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Grade 3 or 4 Laboratory Abnormalities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1763</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [1.25, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Delayed vs Immediate ART (RCTs)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009153-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Treated with ART vs Not Treated with ART (Observational Studies)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incident HIV Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.35, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Treated with ART vs Not Treated with ART (Observational Studies)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009153-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incident HIV Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.17, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Treated with ART vs Not Treated with ART (Observational Studies, sensitivity analysis)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009153-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Treated with ART vs Not Treated with ART (&lt; 200, 200‐349, and ≥350 CD4 Cells/µL Subgroup Analysis) (Observational Studies)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incident HIV Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Less than 200 CD4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.02, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 200‐350 CD4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.47, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 More than 350 CD4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 1.99]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Treated with ART vs Not Treated with ART (&lt; 200, 200‐349, and ≥350 CD4 Cells/µL Subgroup Analysis) (Observational Studies)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009153-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Treated with ART vs Not Treated with ART (Female/Male Subgroup Analysis) (Observational Studies)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incident HIV Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Female Index Case</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.13, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Male Index Case</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 1.62]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Treated with ART vs Not Treated with ART (Female/Male Subgroup Analysis) (Observational Studies)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009153-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Treated with ART vs Not Treated with ART (Subgroup Analysis: Low‐/Middle‐Income vs High‐income)) (Observational Studies)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incident HIV Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low/Middle Income Country</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.29, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 High Income Country</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.33, 1.83]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Treated with ART vs Not Treated with ART (Subgroup Analysis: Low‐/Middle‐Income vs High‐income)) (Observational Studies)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009153.pub3/references#CD009153-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009153.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009153-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009153-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009153-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD009153-note-0001">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009153\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009153\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009153\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009153\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009153\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009153.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009153.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009153.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009153.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009153.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718566440"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009153.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718566444"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009153.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd3794f0ef401',t:'MTc0MDcxODU2Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 